data_2jgw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jgw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.749 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.512 HD22 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.621 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.861 HD21 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.621 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.861 ' HZ ' HD21 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.615 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.3 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.799 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.73 HD12 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.811 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.615 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.749 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.638 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.637 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.811 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.512 ' SG ' HD22 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.512 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.507 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.512 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.507 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.728 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.728 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.697 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.697 HD13 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.818 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.616 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.441 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.548 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.694 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.818 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.745 ' HG3' HG23 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 445' ' ' VAL . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.052 0.454 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.403 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.3 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HA ' HD13 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.838 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 437' ' ' SER . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.572 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.677 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.838 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.641 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.611 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.577 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.52 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.621 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.641 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.753 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.611 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.88 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.911 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.696 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.491 HD23 HG13 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.576 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.52 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.911 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 36.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.454 ' OG ' HG23 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.491 HG13 HD23 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.864 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.696 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.627 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.864 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.411 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.844 0.354 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.863 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.408 ' HE1' HG23 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.504 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 394' ' ' LEU . 0.5 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.57 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.496 ' HA3' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 433' ' ' GLU . 45.8 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.404 ' HE2' HG11 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.531 ' OG ' HG23 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.516 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 422' ' ' LEU . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.623 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.563 ' HA ' HE21 ' A' ' 408' ' ' GLN . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.658 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.709 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.709 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.612 ' HB3' HG22 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 423' ' ' PRO . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.588 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.553 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 405' ' ' LYS . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.903 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.483 ' OG ' HG23 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.634 ' HA ' HD13 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.973 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.507 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.709 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.973 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.476 ' HD3' HG23 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.588 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.566 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.561 ' HG3' HD21 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.561 HD21 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.1 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.637 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.595 ' HA ' HD13 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 1.037 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.549 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.736 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 1.037 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 120.981 0.419 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.411 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.684 ' CD2' ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.617 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 2.4 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.487 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.487 ' OG ' HG21 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.608 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.969 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.527 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.518 ' HE1' ' OD1' ' A' ' 434' ' ' ASN . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 432' ' ' MET . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . 0.518 ' OD1' ' HE1' ' A' ' 432' ' ' MET . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.527 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.534 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.969 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.684 ' HA ' ' CD2' ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.623 ' H ' HD11 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.868 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.584 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.584 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.868 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.688 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.524 HG21 HG13 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.864 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.688 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.784 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.864 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.899 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.49 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.431 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.899 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.684 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.8 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.516 ' OG ' HG23 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.528 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.673 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.684 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.921 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.573 ' HB2' ' NE2' ' A' ' 408' ' ' GLN . 12.3 mmm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.562 ' HB2' ' NZ ' ' A' ' 410' ' ' LYS . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.491 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.504 HD22 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.491 ' NE2' ' HB2' ' A' ' 393' ' ' TYR . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.958 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.437 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 387' ' ' ARG . 35.6 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.958 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.452 ' OG ' HG23 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.632 ' HB3' ' HZ3' ' A' ' 424' ' ' LYS . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.649 ' HB2' ' HZ2' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.531 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.559 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.752 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.708 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 120.988 0.423 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.599 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.54 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.408 ' H ' ' NE2' ' A' ' 402' ' ' HIS . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 1.064 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 1.064 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.671 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 34.9 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.493 ' CB ' HG21 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.745 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.745 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.907 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.671 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.698 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.622 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.907 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.8 ' HZ ' HG23 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.626 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.1 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.8 HG23 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.559 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.497 ' HA ' HD12 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.907 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.499 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.511 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.499 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.663 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.559 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.907 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.791 0.329 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.522 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.484 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.469 ' CB ' HG21 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.7 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.469 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.656 ' HA ' HD13 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.842 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.521 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.561 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.616 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.842 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.849 ' HZ ' ' N ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . 0.476 ' O ' HD13 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.849 ' N ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.761 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.456 ' CB ' HG21 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.653 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.9 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.761 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.815 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.69 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.788 ' HB3' HG12 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.653 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.721 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.721 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.478 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.866 ' HD2' ' HB1' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . 0.866 ' HB1' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.812 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.649 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 439' ' ' THR . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.558 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.305 1.05 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . 0.648 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.522 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . 0.648 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.522 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 431' ' ' CYS . 8.8 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HG3' HG11 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.804 ' HB ' HD22 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.804 HD22 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.9 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.961 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.573 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.665 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.961 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.499 ' HG3' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . 0.684 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.613 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 1.024 ' HH ' HG12 ' A' ' 414' ' ' VAL . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.456 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.726 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.6 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG23 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 1.024 HG12 ' HH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.699 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . 0.613 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . 0.712 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.871 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.726 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.684 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.604 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.739 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.871 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.628 ' HB3' ' HZ3' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.443 -0.794 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.744 ' HG2' HG22 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' TYR . . . . . 0.869 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.54 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' GLN . . . . . 0.425 ' N ' HG21 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.428 ' CB ' HG21 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' CYS . . . . . 0.869 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.426 ' HA3' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.998 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' CYS . . . . . 0.519 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . 0.519 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' TRP . . . . . 0.614 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' SER . . . . . 0.711 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.998 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . 0.426 ' HE2' ' HA3' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.019 0.437 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -97.24 88.64 4.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.489 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.749 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.458 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.512 HD22 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.621 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.861 HD21 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.621 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.458 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.861 ' HZ ' HD21 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.615 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.3 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.578 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.799 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.73 ' HB ' HD12 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.73 HD12 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.811 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.615 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.749 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.638 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.637 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.811 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.512 ' SG ' HD22 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.622 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -84.09 95.77 8.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.512 ' CZ ' ' HA3' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.507 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.512 ' HA3' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.507 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.728 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.728 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.697 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.697 HD13 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.818 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.616 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.441 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.548 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.694 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.818 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.745 ' HG3' HG23 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 445' ' ' VAL . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 -76.28 88.2 3.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.647 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.403 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.59 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.572 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.3 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.48 ' OG ' HG21 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.698 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.437 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HA ' HD13 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.838 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.48 ' SD ' ' HB2' ' A' ' 437' ' ' SER . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.572 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.647 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.677 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.838 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 386' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.948 0.404 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 -124.4 77.15 1.54 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.641 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.611 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.577 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.52 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.621 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.88 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.641 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.753 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.611 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.88 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.911 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -68.15 50.38 0.06 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 171.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.696 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.491 HD23 HG13 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.576 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.52 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.911 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 36.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.454 ' OG ' HG23 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.491 HG13 HD23 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.864 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.555 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.696 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.627 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.717 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.864 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.411 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.578 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.709 0.29 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? -79.24 94.45 5.43 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.22 -176.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.658 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.863 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.408 ' HE1' HG23 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.504 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.504 ' ND2' ' H ' ' A' ' 394' ' ' LEU . 0.5 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.57 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.496 ' HA3' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.404 HG11 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.563 HE21 ' HA ' ' A' ' 433' ' ' GLU . 45.8 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.404 ' HE2' HG11 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.531 ' OG ' HG23 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.516 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 422' ' ' LEU . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.623 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.563 ' HA ' HE21 ' A' ' 408' ' ' GLN . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.658 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.709 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.709 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.612 ' HB3' HG22 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 423' ' ' PRO . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 388' ' ' LYS . 95.3 mt . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.9 0.381 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.455 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER 42.81 32.9 0.43 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 175.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.693 ' HB3' ' HA3' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.414 ' N ' HD13 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.588 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.553 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 405' ' ' LYS . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.903 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.483 ' OG ' HG23 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.666 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.634 ' HA ' HD13 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.973 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.507 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA3' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.709 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.973 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.476 ' HD3' HG23 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.55 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.588 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.634 HD13 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.229 0.538 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -76.39 91.11 3.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.448 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.566 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.561 ' HG3' HD21 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.561 HD21 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.549 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.1 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.637 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.595 ' HA ' HD13 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.611 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 1.037 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.549 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.736 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 1.037 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.595 HD13 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 -86.09 99.0 11.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.929 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.411 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.684 ' CD2' ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.617 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 2.4 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.487 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.487 ' OG ' HG21 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.608 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.72 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.969 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.527 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.518 ' HE1' ' OD1' ' A' ' 434' ' ' ASN . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' A' ' 432' ' ' MET . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.518 ' OD1' ' HE1' ' A' ' 432' ' ' MET . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.527 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.534 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.969 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.684 ' HA ' ' CD2' ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.623 ' H ' HD11 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 388' ' ' LYS . 10.1 mp . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER -40.1 80.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.838 1.255 . . . . 0.0 113.859 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 386' ' ' LEU . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.868 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.439 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.584 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.584 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.868 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.688 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.524 HG21 HG13 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.864 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.688 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.784 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.864 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 434' ' ' ASN . 9.3 mp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 59.42 31.11 20.84 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.899 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.49 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.431 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.47 HD21 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.506 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.899 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.684 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.8 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.516 ' OG ' HG23 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.528 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.673 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.684 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . 0.701 ' HA ' HD23 ' A' ' 386' ' ' LEU . 1.8 m120 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.921 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.523 ' HB2' ' HA3' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.573 ' HB2' ' NE2' ' A' ' 408' ' ' GLN . 12.3 mmm180 -74.77 77.86 2.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.562 ' HB2' ' NZ ' ' A' ' 410' ' ' LYS . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.491 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.504 HD22 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.491 ' NE2' ' HB2' ' A' ' 393' ' ' TYR . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.958 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.437 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 387' ' ' ARG . 35.6 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.958 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.452 ' OG ' HG23 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.427 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.484 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.632 ' HB3' ' HZ3' ' A' ' 424' ' ' LYS . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.798 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.649 ' HB2' ' HZ2' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.531 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.559 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.752 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.708 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.798 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.504 ' SG ' HD22 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.426 -1.668 0 CA-C-O 122.81 1.29 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.473 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? -118.36 81.98 1.77 Allowed 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.585 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.599 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.54 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.408 ' H ' ' NE2' ' A' ' 402' ' ' HIS . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 1.064 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 1.064 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.671 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 34.9 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.493 ' CB ' HG21 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.745 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.44 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.745 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.907 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.671 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.698 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.622 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.907 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -79.73 88.81 5.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.588 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.8 ' HZ ' HG23 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.632 HD13 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.626 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.1 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.538 ' OG ' HG23 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.8 HG23 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.559 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.497 ' HA ' HD12 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.907 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.499 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.511 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.499 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.663 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.559 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.907 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HB2' HD13 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.67 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.761 -0.089 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.55 86.67 6.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.278 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . 0.484 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.609 HD21 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.454 ' HB2' ' CE1' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.522 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.484 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.522 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.469 ' CB ' HG21 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.675 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.401 HG22 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.609 ' SG ' HD21 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.7 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.469 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.656 ' HA ' HD13 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.842 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.521 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.561 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.616 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.842 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.56 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.421 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -89.41 82.81 6.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.652 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.849 ' HZ ' ' N ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . 0.476 ' O ' HD13 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.41 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.652 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.849 ' N ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.761 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.456 ' CB ' HG21 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.444 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.653 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.9 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 1.016 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.761 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.644 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.815 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.69 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 1.016 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.788 ' HB3' HG12 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.653 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.411 HD13 ' N ' ' A' ' 386' ' ' LEU . 8.8 mp . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.721 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 -87.27 91.9 8.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.435 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.721 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.478 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.668 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.449 ' HA ' ' HA3' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.812 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.866 ' HD2' ' HB1' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.866 ' HB1' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.812 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.488 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.649 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.631 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 439' ' ' THR . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 408' ' ' GLN . 6.4 mp . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 122.094 0.95 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.558 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 -77.45 9.27 3.38 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.092 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 386' ' ' LEU . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.648 ' CE1' ' HA3' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.552 HD22 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.522 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . 0.648 ' HA3' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.522 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.443 HG11 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.633 ' HB3' ' HG ' ' A' ' 386' ' ' LEU . 8.8 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HG3' HG11 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.444 ' OG ' HG21 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.804 ' HB ' HD22 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.804 HD22 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.9 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.961 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.573 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.665 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.961 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.499 ' HG3' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER 52.53 18.31 0.94 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 -174.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . 0.684 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.613 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 1.024 ' HH ' HG12 ' A' ' 414' ' ' VAL . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.456 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.726 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.6 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG23 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 1.024 HG12 ' HH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.699 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . 0.613 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . 0.712 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.871 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.726 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.684 ' HA3' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.604 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.739 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.871 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.712 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.628 ' HB3' ' HZ3' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.435 ' HG ' ' HG2' ' A' ' 387' ' ' ARG . 18.5 tp . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.133 0.492 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.435 ' HG2' ' HG ' ' A' ' 386' ' ' LEU . 2.3 mmp_? -101.46 79.62 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.11 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.744 ' HG2' HG22 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' PHE . . . . . 0.512 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' TYR . . . . . 0.869 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.54 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.744 HG22 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.425 ' N ' HG21 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.428 ' CB ' HG21 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' CYS . . . . . 0.869 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.426 ' HA3' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.998 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' CYS . . . . . 0.519 ' SG ' ' HA3' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' MET . . . . . 0.587 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . 0.519 ' HA3' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' TRP . . . . . 0.614 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.711 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.998 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.426 ' HE2' ' HA3' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.535 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.639 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.858 HD22 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.639 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.858 ' HZ ' HD22 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 25.2 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.585 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.816 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.637 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.658 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.816 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.549 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.491 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.417 ' HB2' HE22 ' A' ' 400' ' ' GLN . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.417 HE22 ' HB2' ' A' ' 398' ' ' TYR . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.703 ' HB ' HD11 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.709 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.709 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.823 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.837 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.598 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.491 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.703 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.837 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.748 ' HG3' HG21 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.052 0.454 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.564 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 28.5 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.495 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.429 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 426' ' ' GLN . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 424' ' ' LYS . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.853 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 432' ' ' MET . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.68 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.746 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.853 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.617 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 396' ' ' ASN . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.794 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.531 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.401 HG12 ' HE2' ' A' ' 410' ' ' LYS . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.401 ' HE2' HG12 ' A' ' 407' ' ' VAL . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.877 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.536 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.757 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.629 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.877 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.504 ' HG2' HG22 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 443' ' ' ILE . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.921 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.5 HD22 HG11 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.921 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 26.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.5 HG11 HD22 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 424' ' ' LYS . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.783 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.612 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 430' ' ' THR . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.718 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.849 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.422 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 444' ' ' ARG . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.576 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.844 0.354 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HE1' HG22 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.49 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.4 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.568 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.568 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.868 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 9.0 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.537 ' OG ' HG22 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.414 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.529 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.684 HG23 ' HD2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 432' ' ' MET . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.618 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.729 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.729 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.636 ' HB3' HG21 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.704 ' HB3' ' HA2' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.56 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 47.3 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.925 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.71 ' HA ' HD11 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 435' ' ' GLY . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.489 ' HD3' HG21 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.572 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.785 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 26.2 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.826 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.785 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.62 ' HA ' HD11 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 1.039 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.739 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 1.039 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 120.981 0.419 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.413 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.63 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 21.9 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.413 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.512 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.642 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.638 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.753 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.753 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.651 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.554 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HA ' HD21 ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.696 ' H ' HD13 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.651 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.603 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.603 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.892 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.651 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 48.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.874 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.676 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.55 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.874 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.926 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.492 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.443 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.518 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.926 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 25.1 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.566 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD11 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.912 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.556 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.634 ' HA ' ' O ' ' A' ' 430' ' ' THR . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.912 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.439 HG13 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 12.3 mmm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.564 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.496 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.524 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.972 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.573 ' HA ' ' SG ' ' A' ' 431' ' ' CYS . 26.3 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.972 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.446 ' OG ' HG22 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.501 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.814 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 432' ' ' MET . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.767 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.73 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.814 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.524 ' SG ' HD23 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.486 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 120.988 0.423 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.55 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 1.089 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 1.089 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 431' ' ' CYS . 26.4 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.506 ' CB ' HG22 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.796 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 438' ' ' PRO . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.796 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.927 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.532 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.622 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.708 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.927 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 446' ' ' LYS . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.81 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.454 ' ND1' ' O ' ' A' ' 391' ' ' PHE . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 22.9 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.81 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.689 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 432' ' ' MET . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.672 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.581 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.93 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.663 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 446' ' ' LYS . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.791 0.329 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.601 HD23 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.536 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG22 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.482 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.674 ' HA ' HD11 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.83 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.534 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.564 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.83 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.657 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.851 ' HZ ' ' H ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.402 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.657 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.851 ' H ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.771 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.471 ' CB ' HG22 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.476 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.3 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.972 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.771 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.657 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.811 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.705 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.972 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.801 ' HB3' HG11 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.662 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.734 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 407' ' ' VAL . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.47 HD23 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 388' ' ' LYS . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.734 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.497 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . 0.888 ' HB3' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.844 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 93.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 441' ' ' ARG . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.47 ' SG ' HD23 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.305 1.05 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' TYR . . . . . 0.651 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.531 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLY . . . . . 0.651 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 431' ' ' CYS . 51.6 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.835 ' HB ' HD21 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.835 HD21 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.8 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.934 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' CYS . . . . . 0.693 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.621 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.708 ' HE2' ' CA ' ' A' ' 416' ' ' CYS . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 20.8 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.667 HG13 ' OH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.708 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' HIS . . . . . 0.621 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 418' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 417' ' ' HIS . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' TYR . . . . . 0.754 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.865 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.561 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.601 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.763 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.865 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.443 -0.794 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.758 ' HG2' HG23 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 402' ' ' HIS . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.539 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.758 HG23 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' CYS . . . . . 0.877 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 411' ' ' SER . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' MET . . . . . 0.588 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' TRP . . . . . 0.615 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 1.032 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' THR . . . . . 0.642 HG22 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' LYS . . . . . 0.451 ' HE2' ' HA2' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.019 0.437 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -97.24 88.64 4.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.489 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.535 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.639 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.858 HD22 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.639 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.858 ' HZ ' HD22 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 25.2 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.585 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.816 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.471 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.637 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.658 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.816 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.549 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -84.09 95.77 8.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.491 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.417 ' HB2' HE22 ' A' ' 400' ' ' GLN . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.417 HE22 ' HB2' ' A' ' 398' ' ' TYR . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.703 ' HB ' HD11 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.709 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.709 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.823 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.837 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.598 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.491 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.703 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.837 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.748 ' HG3' HG21 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 -76.28 88.2 3.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.564 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 387' ' ' ARG . 28.5 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.495 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.429 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 426' ' ' GLN . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 424' ' ' LYS . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.853 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.48 ' N ' ' HG3' ' A' ' 432' ' ' MET . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.68 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.746 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.853 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 386' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.948 0.404 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 -124.4 77.15 1.54 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.617 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 396' ' ' ASN . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.794 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.531 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.401 HG12 ' HE2' ' A' ' 410' ' ' LYS . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.401 ' HE2' HG12 ' A' ' 407' ' ' VAL . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.794 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.877 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.536 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.757 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.629 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.877 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.504 ' HG2' HG22 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 443' ' ' ILE . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 434' ' ' ASN . 92.0 mt . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.921 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -68.15 50.38 0.06 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 171.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.5 HD22 HG11 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.921 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 26.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.5 HG11 HD22 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 424' ' ' LYS . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.783 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.612 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 386' ' ' LEU . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 430' ' ' THR . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.718 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.849 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.422 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 444' ' ' ARG . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.576 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.709 0.29 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? -79.24 94.45 5.43 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.22 -176.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HE1' HG22 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.49 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.4 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.568 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.568 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.868 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 9.0 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.537 ' OG ' HG22 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.414 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.529 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.684 HG23 ' HD2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.523 ' N ' ' HG3' ' A' ' 432' ' ' MET . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.618 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.729 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.729 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.636 ' HB3' HG21 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' A' ' 388' ' ' LYS . 95.3 mt . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.9 0.381 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER 42.81 32.9 0.43 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 175.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.704 ' HB3' ' HA2' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.56 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.485 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 47.3 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.925 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.71 ' HA ' HD11 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 435' ' ' GLY . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.489 ' HD3' HG21 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.572 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.229 0.538 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -76.39 91.11 3.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.448 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.785 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 26.2 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.826 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.785 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.62 ' HA ' HD11 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 1.039 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.739 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 1.039 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 -86.09 99.0 11.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.929 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.413 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.63 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 21.9 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.413 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.512 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.642 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.638 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.753 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.753 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.651 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.554 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HA ' HD21 ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.696 ' H ' HD13 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 388' ' ' LYS . 10.1 mp . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.651 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER -40.1 80.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.838 1.255 . . . . 0.0 113.859 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 386' ' ' LEU . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.603 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.603 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.892 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.651 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 48.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.874 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.676 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.55 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.874 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 434' ' ' ASN . 9.3 mp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 59.42 31.11 20.84 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.926 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.492 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.443 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.518 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.926 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 25.1 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.566 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD11 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.912 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.556 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ASN . . . . . 0.735 ' HA ' HD22 ' A' ' 386' ' ' LEU . 33.1 m-20 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.634 ' HA ' ' O ' ' A' ' 430' ' ' THR . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.912 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.439 HG13 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 12.3 mmm180 -74.77 77.86 2.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.564 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.496 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.524 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.972 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.573 ' HA ' ' SG ' ' A' ' 431' ' ' CYS . 26.3 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.972 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.446 ' OG ' HG22 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.501 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.814 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 432' ' ' MET . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.767 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.73 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.814 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.524 ' SG ' HD23 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.426 -1.668 0 CA-C-O 122.81 1.29 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.486 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? -118.36 81.98 1.77 Allowed 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.585 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.55 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 1.089 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 1.089 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 431' ' ' CYS . 26.4 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.506 ' CB ' HG22 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.796 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 438' ' ' PRO . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.796 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.927 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.532 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.622 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.708 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.927 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 446' ' ' LYS . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -79.73 88.81 5.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.588 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.81 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.454 ' ND1' ' O ' ' A' ' 391' ' ' PHE . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 22.9 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.81 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.689 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 432' ' ' MET . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.672 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.581 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.93 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.663 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 446' ' ' LYS . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.761 -0.089 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.55 86.67 6.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.278 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.601 HD23 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.536 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG22 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 396' ' ' ASN . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.482 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.674 ' HA ' HD11 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.83 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.534 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.564 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.83 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -89.41 82.81 6.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.657 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.851 ' HZ ' ' H ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.402 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.657 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.851 ' H ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.771 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.471 ' CB ' HG22 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.476 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 97.3 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.972 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.771 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.657 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.811 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.705 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.972 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.801 ' HB3' HG11 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.662 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 386' ' ' LEU . 8.8 mp . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.734 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 -87.27 91.9 8.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 407' ' ' VAL . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.47 HD23 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 388' ' ' LYS . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.734 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.497 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.888 ' HB3' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.844 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 93.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 441' ' ' ARG . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.47 ' SG ' HD23 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 408' ' ' GLN . 6.4 mp . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 122.094 0.95 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 -77.45 9.27 3.38 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.092 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.651 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.531 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . 0.651 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.67 ' HB3' ' HG ' ' A' ' 386' ' ' LEU . 51.6 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.835 ' HB ' HD21 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.835 HD21 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.8 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.934 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 386' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER 52.53 18.31 0.94 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 -174.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' CYS . . . . . 0.693 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.621 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.708 ' HE2' ' CA ' ' A' ' 416' ' ' CYS . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 433' ' ' GLU . 20.8 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.667 HG13 ' OH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.708 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' HIS . . . . . 0.621 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 418' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 417' ' ' HIS . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' TYR . . . . . 0.754 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.865 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.561 ' HA ' ' OE1' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.601 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.763 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.865 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.454 ' HG ' ' HG2' ' A' ' 387' ' ' ARG . 18.5 tp . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.133 0.492 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.454 ' HG2' ' HG ' ' A' ' 386' ' ' LEU . 2.3 mmp_? -101.46 79.62 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.11 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.758 ' HG2' HG23 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 402' ' ' HIS . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.539 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.758 HG23 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' CYS . . . . . 0.877 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 411' ' ' SER . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' MET . . . . . 0.588 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' TRP . . . . . 0.615 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 1.032 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' THR . . . . . 0.642 HG22 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.451 ' HE2' ' HA2' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.535 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.639 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.858 HD22 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.639 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.858 ' HZ ' HD22 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.3 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.585 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.816 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.621 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.637 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.658 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.816 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.549 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.491 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.417 ' HB2' HE22 ' A' ' 400' ' ' GLN . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.417 HE22 ' HB2' ' A' ' 398' ' ' TYR . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.703 ' HB ' HD11 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.709 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.709 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.823 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.837 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.598 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.491 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.703 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.837 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.748 ' HG3' HG21 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.052 0.454 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.564 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.58 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.3 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.495 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.429 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 426' ' ' GLN . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 424' ' ' LYS . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.853 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.58 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.68 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.746 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.853 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 . . . . . 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.617 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 396' ' ' ASN . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.594 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.531 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.401 HG12 ' HE2' ' A' ' 410' ' ' LYS . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.401 ' HE2' HG12 ' A' ' 407' ' ' VAL . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.713 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.877 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.536 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.757 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.629 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.877 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.504 ' HG2' HG22 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 443' ' ' ILE . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.921 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.5 HD22 HG11 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.921 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 36.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.5 HG11 HD22 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 424' ' ' LYS . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.783 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.612 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 430' ' ' THR . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.718 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.849 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.422 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 444' ' ' ARG . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.576 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.844 0.354 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HE1' HG22 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.571 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 394' ' ' LEU . 0.5 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.568 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.568 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.868 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 433' ' ' GLU . 45.8 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.537 ' OG ' HG22 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.414 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.529 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.684 HG23 ' HD2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.58 ' HA ' HE21 ' A' ' 408' ' ' GLN . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.618 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.729 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.729 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.636 ' HB3' HG21 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.704 ' HB3' ' HA2' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.56 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.525 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.925 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.71 ' HA ' HD11 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 435' ' ' GLY . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.525 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.489 ' HD3' HG21 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.572 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.579 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.1 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.826 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.676 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.62 ' HA ' HD11 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 1.039 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.739 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 1.039 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 . . . . . 0 N--CA 1.446 -0.637 0 CA-C-O 120.981 0.419 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.413 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.63 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 2.4 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.413 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.512 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.642 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.638 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.753 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.753 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.651 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.554 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HA ' HD21 ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.696 ' H ' HD13 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.651 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.245 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.603 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.603 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.892 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.698 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.874 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.676 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.698 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.874 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.926 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.492 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.443 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.518 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.926 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.698 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.8 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.566 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD11 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.912 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.698 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.634 ' HA ' ' O ' ' A' ' 430' ' ' THR . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.912 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.439 HG13 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.592 ' HB2' ' NE2' ' A' ' 408' ' ' GLN . 12.3 mmm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.564 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.496 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.524 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.972 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' ' 387' ' ' ARG . 35.6 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.972 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.446 ' OG ' HG22 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.501 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.814 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.539 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.767 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.73 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.814 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.524 ' SG ' HD23 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.486 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? . . . . . 0 N--CA 1.448 -0.54 0 CA-C-O 120.988 0.423 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.55 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 1.089 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 1.089 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.682 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 34.9 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.506 ' CB ' HG22 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.796 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 438' ' ' PRO . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.796 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.927 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.682 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.622 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.708 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.927 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 446' ' ' LYS . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.644 0.259 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.81 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.454 ' ND1' ' O ' ' A' ' 391' ' ' PHE . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.639 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.1 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.81 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.689 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.639 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.672 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.581 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.93 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.663 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 446' ' ' LYS . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.791 0.329 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.601 HD23 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.536 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG22 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.775 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.482 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.674 ' HA ' HD11 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.83 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.534 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.564 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.83 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.657 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.851 ' HZ ' ' H ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.402 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.657 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.851 ' H ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.771 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.471 ' CB ' HG22 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.476 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.9 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.972 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.771 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.657 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.811 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.705 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.972 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.801 ' HB3' HG11 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.662 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.734 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 407' ' ' VAL . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.47 HD23 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 388' ' ' LYS . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.734 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.497 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . 0.888 ' HB3' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.844 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 441' ' ' ARG . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.47 ' SG ' HD23 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 122.305 1.05 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . 0.651 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.531 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . 0.651 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 431' ' ' CYS . 8.8 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.835 ' HB ' HD21 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.835 HD21 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.9 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.934 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.418 HG21 HE22 ' A' ' 426' ' ' GLN . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . 0.693 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.621 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.708 ' HE2' ' CA ' ' A' ' 416' ' ' CYS . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.734 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.6 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.667 HG13 ' OH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.708 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . 0.621 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 417' ' ' HIS . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . 0.754 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.865 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.734 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.601 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.763 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.865 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.443 -0.794 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.758 ' HG2' HG23 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 402' ' ' HIS . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.539 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.758 HG23 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' CYS . . . . . 0.877 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 411' ' ' SER . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' MET . . . . . 0.588 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' TRP . . . . . 0.615 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 1.032 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' THR . . . . . 0.642 HG22 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . 0.451 ' HE2' ' HA2' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.019 0.437 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -97.24 88.64 4.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.489 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -74.36 149.58 40.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.492 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.755 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -117.63 114.97 24.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.12 0.486 . . . . 0.0 111.665 -175.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.46 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 53.1 t80 -83.55 129.05 34.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.305 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -76.04 115.77 49.64 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.4 -168.94 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.417 2.745 . . . . 0.0 112.964 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -115.97 114.08 24.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.903 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.535 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.5 mp -86.13 132.59 33.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 172.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.61 -52.74 63.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.058 -173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.25 31.01 6.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -118.46 177.14 16.37 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.964 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.45 90.88 4.93 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.639 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 19.6 m-80 -75.22 76.83 2.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.907 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -51.46 -48.95 62.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.386 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.858 HD22 ' HZ ' ' A' ' 406' ' ' PHE . 3.4 m-20 -109.96 38.94 2.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.569 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.639 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 17.2 t-80 -55.01 132.06 46.25 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 176.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 78.1 27.85 57.34 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.838 172.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.16 140.34 52.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.822 0.344 . . . . 0.0 110.65 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -98.21 130.97 44.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.858 ' HZ ' HD22 ' A' ' 401' ' ' ASN . 96.5 m-85 -117.62 137.71 52.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.963 0.411 . . . . 0.0 110.612 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.81 144.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.012 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.621 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.3 tt0 -49.84 118.94 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.848 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 121.0 -13.16 9.75 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.812 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -97.64 160.75 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.137 0.469 . . . . 0.0 110.887 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.585 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 47.4 t -133.09 168.37 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.008 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.5 tp -170.43 135.9 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.317 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.3 p-10 -82.88 146.84 28.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.979 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 422' ' ' LEU . 68.9 t -119.4 117.64 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.368 0.604 . . . . 0.0 110.998 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -102.42 151.78 21.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.597 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 2.3 t -130.62 175.94 8.59 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.341 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -65.04 163.71 28.02 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.67 111.05 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.982 2.455 . . . . 0.0 112.327 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 117.54 -6.17 16.54 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.587 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 444' ' ' ARG . 29.2 m-85 -116.91 152.49 34.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.52 156.26 23.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.647 0.26 . . . . 0.0 110.742 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 414' ' ' VAL . 39.8 mt -63.03 148.23 92.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.377 0.608 . . . . 0.0 111.193 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 441' ' ' ARG . 74.9 Cg_exo -53.51 144.01 53.3 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 124.023 3.149 . . . . 0.0 112.397 178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 61.85 28.43 17.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.5 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.47 35.27 22.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.974 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.8 mm100 -81.65 157.93 24.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.502 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 5.2 p -123.64 -12.82 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.275 0.559 . . . . 0.0 109.916 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -133.83 157.29 46.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.277 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.816 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.2 p -142.29 140.78 28.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' A' ' 411' ' ' SER . 0.1 OUTLIER -142.38 160.29 40.55 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.846 0.831 . . . . 0.0 112.913 -176.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.2 t -85.13 83.15 8.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.744 -1.571 . . . . 0.0 108.981 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.601 ' SD ' ' HB3' ' A' ' 437' ' ' SER . 19.9 ptm -70.58 -43.06 70.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.274 -173.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.621 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 36.8 tt0 -175.21 -65.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.81 0.338 . . . . 0.0 110.174 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -77.39 -13.05 60.01 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.755 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 150.49 -159.0 27.94 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.628 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.637 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 68.8 m95 -60.9 109.24 1.01 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.658 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.3 p -69.83 -51.32 15.49 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.684 -168.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.816 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.1 Cg_exo -64.11 -23.19 67.2 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.138 1.892 . . . . 0.0 112.011 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.2 m 68.87 110.03 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.818 -174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 49.9 Cg_endo -75.49 83.41 1.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.846 2.364 . . . . 0.0 113.043 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.549 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 99.7 mtt180 -140.39 97.3 3.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.366 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 394' ' ' LEU . 25.1 p -79.25 82.18 5.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.898 0.856 . . . . 0.0 111.188 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 12.5 pt -68.36 147.4 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.562 176.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.65 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 37.3 ttp180 -66.72 113.74 5.07 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.569 0.7 . . . . 0.0 110.5 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.36 -21.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.425 -1.262 . . . . 0.0 110.288 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.753 175.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -84.09 95.77 8.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.145 0.498 . . . . 0.0 110.426 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -83.34 148.08 27.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.961 173.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.491 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 22.7 m -121.32 116.96 25.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.771 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.519 ' CZ ' ' HA2' ' A' ' 403' ' ' GLY . 81.4 t80 -83.63 129.06 34.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.314 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -73.9 119.13 74.61 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.774 0.321 . . . . 0.0 110.223 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 87.5 Cg_endo -81.64 172.9 11.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.968 2.445 . . . . 0.0 112.914 -174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -93.78 119.32 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.398 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 394' ' ' LEU . 5.6 mp -88.84 129.42 35.59 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -58.29 -32.48 68.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.437 -171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -146.76 47.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.442 0.639 . . . . 0.0 111.47 -177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -131.74 171.44 21.27 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.417 ' HB2' HE22 ' A' ' 400' ' ' GLN . 80.4 m-85 -85.4 107.52 17.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.9 OUTLIER -86.43 77.29 9.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 -174.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.417 HE22 ' HB2' ' A' ' 398' ' ' TYR . 2.7 mp0 -66.12 -35.23 79.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.903 0.382 . . . . 0.0 110.834 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 90.2 m-20 -111.3 27.82 9.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.953 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.8 t-160 -60.63 108.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.939 0.4 . . . . 0.0 111.013 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.519 ' HA2' ' CZ ' ' A' ' 390' ' ' TYR . . . 96.81 15.31 40.11 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.642 175.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 86.6 mtt180 -100.85 138.63 37.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.478 . . . . 0.0 111.114 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -100.32 116.32 32.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.659 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -100.94 177.09 5.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.757 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 408' ' ' GLN . 13.7 p -123.08 165.65 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 1.1 tp-100 -50.76 135.02 24.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.947 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.93 -15.83 60.88 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.167 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -74.51 126.6 31.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.168 0.509 . . . . 0.0 110.623 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 430' ' ' THR . 34.9 t -112.85 167.65 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.852 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.2 tp -167.02 135.83 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.839 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.9 p-10 -84.01 123.25 29.8 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 173.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.703 ' HB ' HD11 ' A' ' 422' ' ' LEU . 67.8 t -88.3 131.41 35.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.681 -179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -93.77 106.2 18.19 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.773 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 97.6 m -105.32 154.34 20.41 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.791 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.709 ' CG ' ' HD2' ' A' ' 418' ' ' PRO . 9.6 t-80 -73.76 147.38 86.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.574 0.702 . . . . 0.0 109.691 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.709 ' HD2' ' CG ' ' A' ' 417' ' ' HIS . 82.5 Cg_exo -46.02 120.63 3.7 Favored 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 125.111 3.874 . . . . 0.0 111.984 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.39 -17.76 28.39 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.733 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 86.4 m-85 -115.16 136.0 53.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -141.27 179.91 6.5 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.251 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 414' ' ' VAL . 53.4 mt -98.37 149.75 36.04 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 121.213 0.53 . . . . 0.0 110.958 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 88.2 Cg_exo -48.02 135.84 23.76 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 124.432 3.422 . . . . 0.0 113.692 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.823 ' HA ' ' HE2' ' A' ' 424' ' ' LYS . 10.2 mmpt? 67.32 28.59 7.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.543 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.73 39.02 24.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.649 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 98.4 mt-30 -96.9 169.03 10.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.6 p -127.67 -9.9 5.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.487 0.661 . . . . 0.0 110.036 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -128.04 148.64 50.55 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.719 -173.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.837 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.7 OUTLIER -132.28 148.6 31.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.6 OUTLIER -147.96 164.26 34.3 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.937 0.875 . . . . 0.0 112.667 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.0 t -82.95 103.1 12.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.299 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.598 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 25.6 ptm -85.11 -41.09 16.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.804 -173.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.45 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 38.4 tt0 -174.7 -67.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.249 0.547 . . . . 0.0 109.96 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -106.53 44.78 1.02 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.102 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.491 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 118.03 -178.46 16.88 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.551 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 430' ' ' THR . 56.4 m95 -61.41 122.88 16.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 122.92 0.488 . . . . 0.0 110.178 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.703 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 1.5 p -65.72 -51.88 46.35 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.582 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.837 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 15.8 Cg_exo -73.7 -23.05 17.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.927 1.752 . . . . 0.0 111.12 175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 25.5 m 66.82 112.74 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.339 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.748 ' HG3' HG21 ' A' ' 429' ' ' VAL . 16.4 Cg_exo -61.1 99.17 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.659 2.24 . . . . 0.0 111.925 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 439' ' ' THR . 13.0 ptt180 -152.91 116.83 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.825 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 70.5 m -79.02 90.24 4.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.431 -178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 14.8 pt -88.65 143.76 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.102 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -76.55 121.92 23.85 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.678 0.751 . . . . 0.0 111.051 -175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.15 45.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.423 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.258 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 408' ' ' GLN . 28.6 mmt180 -76.28 88.2 3.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.115 175.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -94.71 138.75 32.15 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.643 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 87.9 m -102.79 131.1 49.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.283 0.563 . . . . 0.0 111.698 -172.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -85.05 131.64 34.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.421 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -83.99 115.49 60.21 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -84.52 177.5 5.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.029 2.486 . . . . 0.0 112.795 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.4 113.54 25.84 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.3 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 6.3 mp -79.88 119.83 23.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.62 108.97 0.91 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.903 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 66.43 47.77 1.66 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.52 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -128.05 -178.73 15.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.845 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -95.44 80.16 3.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.609 0.718 . . . . 0.0 110.503 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 0.0 OUTLIER -84.09 68.15 9.97 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.159 -177.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -66.21 -17.07 64.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.37 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.564 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 89.6 m-20 -117.82 8.02 12.57 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 15.7 t-80 -52.32 121.55 7.13 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.461 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.19 40.27 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.763 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.564 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 90.9 mtt180 -78.49 162.02 26.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.188 0.518 . . . . 0.0 110.898 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -131.54 121.32 24.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.352 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -108.49 135.09 50.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.476 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 150.46 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.559 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.58 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.3 tt0 -51.42 126.48 17.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.883 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.11 -10.88 40.37 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.865 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -85.78 137.38 32.83 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.291 0.567 . . . . 0.0 111.002 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.495 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.9 t -117.25 168.34 10.4 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.857 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.429 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.0 tp -169.95 134.13 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.743 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 9.2 p-10 -81.29 123.2 28.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.026 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.2 t -121.04 136.21 58.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.578 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -128.81 148.82 50.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.672 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 420' ' ' TYR . 1.6 t -104.03 -175.34 2.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 62.0 m170 -73.48 166.42 44.11 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.073 176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 50.3 Cg_exo -57.63 112.86 1.27 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.739 2.293 . . . . 0.0 111.857 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 120.44 -20.63 8.87 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.769 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 416' ' ' CYS . 83.0 m-85 -112.82 140.07 47.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -147.73 167.96 23.32 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.329 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 38.5 mt -77.99 140.5 62.28 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.002 0.43 . . . . 0.0 110.81 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.534 ' HA ' HD11 ' A' ' 443' ' ' ILE . 87.9 Cg_exo -45.39 -61.06 0.65 Allowed 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 124.507 3.471 . . . . 0.0 113.808 -173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.406 ' HB2' ' HG2' ' A' ' 426' ' ' GLN . 71.9 mmtt -81.78 25.79 0.53 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.15 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.55 42.93 31.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.526 0.679 . . . . 0.0 110.883 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.406 ' HG2' ' HB2' ' A' ' 424' ' ' LYS . 15.8 mm100 -91.03 146.53 23.77 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.568 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 28.5 p -102.75 -15.46 16.28 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -135.41 159.87 40.22 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.64 -170.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.853 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.0 p -144.04 136.64 23.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.681 174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.5 p -130.17 150.32 51.48 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.87 -0.732 . . . . 0.0 112.643 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.82 80.33 8.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.701 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.48 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 25.0 ptm -66.4 -46.93 74.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.762 -171.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.58 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 39.6 tt0 -175.9 -59.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -95.28 35.71 1.29 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.493 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.643 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 108.89 -174.49 18.5 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.415 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.68 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.3 m95 -61.19 116.12 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.746 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 35.0 t -67.22 -54.15 21.0 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.461 -173.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.853 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 41.0 Cg_exo -64.77 -30.44 58.97 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.195 1.93 . . . . 0.0 111.456 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 14.0 m 68.68 117.74 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.436 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.507 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 2.7 Cg_exo -69.62 82.72 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.927 2.418 . . . . 0.0 112.305 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -146.57 107.74 4.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.953 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 394' ' ' LEU . 2.8 p -93.96 124.88 38.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.565 0.698 . . . . 0.0 111.782 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.1 pt -99.71 143.98 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.449 176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -67.08 121.67 16.11 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.466 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.12 -17.44 21.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.547 -170.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.778 178.295 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 386' ' ' LEU . 8.6 mp . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.948 0.404 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 387' ' ' ARG . 27.2 mmt180 -124.4 77.15 1.54 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.112 0.482 . . . . 0.0 111.169 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -89.5 126.42 35.58 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.635 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 35.3 m -85.67 108.99 18.28 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.779 -171.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.617 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 64.2 t80 -66.66 127.24 31.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.178 174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.481 ' HA ' ' HD3' ' A' ' 392' ' ' PRO . 37.1 t80 -82.24 116.49 63.87 Favored Pre-proline 0 C--O 1.239 0.513 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 391' ' ' PHE . 6.2 Cg_endo -80.63 -177.13 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.637 2.891 . . . . 0.0 113.139 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -105.5 107.67 18.78 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.94 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.95 56.6 3.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -172.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.422 ' HB3' ' H ' ' A' ' 396' ' ' ASN . 0.9 OUTLIER 63.83 -83.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.09 0.556 . . . . 0.0 111.82 172.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.594 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 91.8 m-20 -123.62 16.08 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.347 . . . . 0.0 110.15 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -72.85 170.87 51.11 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.965 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 68.8 m-85 -93.47 80.42 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.672 0.749 . . . . 0.0 109.887 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 3.6 m-80 -91.68 67.92 5.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.863 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -71.83 -7.99 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.796 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.531 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 81.5 m-20 -110.94 11.7 22.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.865 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.6 t-80 -61.94 126.12 26.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.151 0.501 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.617 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 96.05 1.1 61.45 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.988 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 99.8 mtt180 -102.09 138.74 38.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 110.644 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -104.26 112.63 25.74 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.007 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -97.1 121.56 39.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.38 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.401 HG12 ' HE2' ' A' ' 410' ' ' LYS . 12.8 p -62.34 149.67 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.196 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 30.0 tt0 -48.33 129.1 15.36 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.297 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 110.8 -23.19 20.17 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.651 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.401 ' HE2' HG12 ' A' ' 407' ' ' VAL . 64.8 mttm -83.81 166.38 18.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.969 0.414 . . . . 0.0 111.432 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 46.8 t -141.33 166.78 23.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.676 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -170.06 139.16 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.643 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.0 p-10 -77.22 142.95 39.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.567 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.93 131.64 57.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.748 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -92.5 92.19 7.96 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.309 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 8.2 m -78.65 150.34 32.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.267 0.556 . . . . 0.0 110.767 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.713 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -66.31 150.33 97.12 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.197 174.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.35 127.44 13.31 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.089 3.193 . . . . 0.0 113.261 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.49 -9.39 76.04 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.367 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 444' ' ' ARG . 94.4 m-85 -113.4 136.64 52.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.76 0.314 . . . . 0.0 110.8 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -145.59 149.62 34.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.111 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 440' ' ' PRO . 53.1 mt -67.46 148.46 98.66 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.957 0.408 . . . . 0.0 110.884 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 94.1 Cg_exo -47.36 136.99 19.37 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 124.172 3.248 . . . . 0.0 112.713 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 59.8 mttp 71.41 21.31 4.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.843 -177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 61.61 36.08 16.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.618 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 49.1 mt-30 -86.92 160.41 18.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.544 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.6 p -122.19 -8.24 8.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.671 0.748 . . . . 0.0 110.208 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -125.78 153.29 44.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.106 -173.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.877 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -137.77 140.34 41.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.881 0.372 . . . . 0.0 110.197 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.1 OUTLIER -132.68 152.96 51.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.454 -176.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 16.3 t -85.17 89.97 7.76 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.308 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.536 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.8 ptm -70.21 -39.37 75.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.296 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.56 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 30.1 tt0 -177.01 -75.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.541 -177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.02 -11.94 59.45 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.115 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.635 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 167.77 -174.49 42.77 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.831 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.757 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.7 m95 -54.49 122.56 10.76 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.928 0.491 . . . . 0.0 109.913 173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.629 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.4 p -76.05 -46.18 3.77 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -171.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.877 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 45.1 Cg_exo -62.95 -19.42 68.96 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.097 1.865 . . . . 0.0 111.608 172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 441' ' ' ARG . 18.9 m 65.38 103.12 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.17 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.632 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.8 Cg_endo -69.69 80.0 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.974 2.449 . . . . 0.0 112.385 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.504 ' HG2' HG22 ' A' ' 439' ' ' THR . 2.1 ptm180 -147.34 76.67 1.42 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.187 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 39.7 m -56.16 99.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.021 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 443' ' ' ILE . 6.6 pt -76.24 149.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.81 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.477 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 67.9 ttt180 -65.94 118.44 9.75 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.443 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.9 p -101.67 -8.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.68 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 25.7 tptp . . . . . 0 C--O 1.245 0.85 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.231 178.863 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 434' ' ' ASN . 92.0 mt . . . . . 0 N--CA 1.452 -0.372 0 CA-C-O 120.699 0.285 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.921 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -68.15 50.38 0.06 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 171.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 388' ' ' LYS . 1.6 tmmt? -158.06 149.76 21.61 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.704 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 41.6 m -150.78 123.06 8.35 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.065 -172.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 55.8 t80 -98.12 134.88 40.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.863 169.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -82.89 112.19 35.94 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.97 -166.18 0.37 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.565 2.844 . . . . 0.0 113.459 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -112.22 117.3 32.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.682 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.5 HD22 HG11 ' A' ' 414' ' ' VAL . 5.5 mp -94.09 133.9 37.08 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -81.16 -19.17 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.17 0.509 . . . . 0.0 110.614 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 7.8 p30 -119.54 26.71 9.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.361 -173.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -147.81 164.89 28.85 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.136 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 90.6 m-85 -86.73 105.83 17.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 12.3 m-80 -83.63 70.99 10.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.44 0.638 . . . . 0.0 110.263 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.74 7.06 5.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.611 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 45.7 m-80 -137.57 13.77 2.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.543 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -58.86 128.16 35.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.926 0.393 . . . . 0.0 111.061 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -13.29 64.7 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.093 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 96.1 mtt180 -80.02 138.05 36.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.953 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -105.63 142.6 35.09 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.373 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -133.05 159.06 41.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.342 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.9 p -102.48 162.91 3.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.921 ' HB2' ' HA ' ' A' ' 387' ' ' ARG . 36.2 tt0 -55.48 129.88 40.55 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.801 0.334 . . . . 0.0 110.563 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 107.01 -18.92 36.02 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.309 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -82.0 148.06 28.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.013 0.435 . . . . 0.0 111.3 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 41.3 t -126.8 166.32 17.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.621 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.6 tp -172.23 139.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.569 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 5.1 p-10 -85.65 149.47 25.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.288 0.566 . . . . 0.0 110.752 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.5 HG11 HD22 ' A' ' 394' ' ' LEU . 58.9 t -111.75 135.61 50.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.846 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -95.03 96.9 9.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.762 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 61.5 m -80.69 152.21 28.53 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.928 0.394 . . . . 0.0 111.036 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -72.71 161.86 77.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.39 114.96 2.15 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.309 2.672 . . . . 0.0 112.978 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 107.26 -5.77 36.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.972 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 84.9 m-85 -114.67 153.19 30.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.24 157.67 28.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 39.2 mt -73.99 147.13 85.82 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.102 0.477 . . . . 0.0 110.394 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 67.5 Cg_exo -46.95 140.1 13.74 Favored 'Trans proline' 0 C--N 1.334 -0.194 0 C-N-CA 124.312 3.342 . . . . 0.0 112.988 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 424' ' ' LYS . 72.6 mmtt 68.66 27.67 5.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.036 -175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.18 51.3 8.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.145 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -106.48 161.3 14.71 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 3.1 p -120.38 -1.69 10.16 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.783 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.77 150.71 50.96 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.824 -171.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.849 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -134.05 133.7 55.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.7 p -129.94 155.98 45.18 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.702 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 9.0 t -85.79 98.04 10.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.612 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 20.7 ptt? -85.88 -153.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.891 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 432' ' ' MET . 24.8 tt0 -54.4 -58.72 6.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.787 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 386' ' ' LEU . 8.5 t30 -107.84 62.12 0.61 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.746 0.784 . . . . 0.0 109.473 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 79.48 -166.47 51.06 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.297 173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 430' ' ' THR . 58.5 m95 -48.8 118.8 2.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.943 0.497 . . . . 0.0 110.647 178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.718 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 19.7 p -79.14 -43.91 1.71 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -172.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.849 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.5 Cg_exo -67.46 -23.5 43.72 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.802 1.668 . . . . 0.0 111.121 172.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 51.4 m 68.05 111.05 0.03 OUTLIER Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.205 -174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.5 Cg_exo -58.29 83.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.376 2.718 . . . . 0.0 113.157 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -145.41 113.1 6.33 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.422 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 95.1 m -80.67 75.49 7.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.348 0.594 . . . . 0.0 109.731 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 22.6 pt -63.86 139.64 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.061 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 444' ' ' ARG . 13.1 ttp180 -65.63 123.63 20.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.634 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.82 -40.17 74.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.752 -1.567 . . . . 0.0 110.232 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.576 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.087 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 120.709 0.29 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 433' ' ' GLU . 6.2 mpt_? -79.24 94.45 5.43 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.22 -176.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -80.36 142.78 34.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.692 0.758 . . . . 0.0 109.314 164.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.4 m -117.85 101.36 8.24 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.713 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.868 ' HA ' ' HB3' ' A' ' 405' ' ' LYS . 68.6 t80 -68.77 127.59 33.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.351 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.411 ' HE1' HG22 ' A' ' 414' ' ' VAL . 39.9 t80 -74.72 118.5 70.66 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -83.7 -176.84 2.88 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.06 2.507 . . . . 0.0 112.977 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -98.05 123.05 41.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.571 ' H ' ' ND2' ' A' ' 399' ' ' ASN . 6.6 mp -102.6 116.99 33.7 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.324 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.5 mp0 -40.01 -67.16 0.25 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 124.205 0.941 . . . . 0.0 112.988 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -111.3 49.04 0.9 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.942 0.401 . . . . 0.0 111.291 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -122.28 -168.21 13.2 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.4 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.415 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 76.7 m-85 -108.29 92.4 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 394' ' ' LEU . 0.5 OUTLIER -87.27 59.04 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.0 0.429 . . . . 0.0 110.922 -173.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -64.16 -17.91 63.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.116 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.568 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 94.1 m-20 -113.6 14.04 18.84 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.573 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.6 t-160 -64.59 111.8 2.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.913 0.387 . . . . 0.0 110.355 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 390' ' ' TYR . . . 111.37 -7.3 28.52 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.568 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 49.0 mtt180 -104.69 130.06 52.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.564 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.868 ' HB3' ' HA ' ' A' ' 390' ' ' TYR . 45.3 pttt -115.25 128.73 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.494 0.664 . . . . 0.0 110.713 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -98.2 145.5 26.55 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.411 -174.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 410' ' ' LYS . 14.6 p -78.15 148.39 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.58 HE21 ' HA ' ' A' ' 433' ' ' GLU . 45.8 tt0 -41.7 124.05 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.069 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 109.11 -18.25 31.16 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.84 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 407' ' ' VAL . 55.7 mttm -89.46 159.01 17.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 0.0 111.384 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.537 ' OG ' HG22 ' A' ' 430' ' ' THR . 48.3 t -133.26 170.68 15.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.091 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.414 HG12 ' ND2' ' A' ' 401' ' ' ASN . 7.7 tp -168.63 134.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.154 0.502 . . . . 0.0 111.313 175.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.5 m-20 -76.27 114.73 15.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.64 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.636 HG21 ' HB3' ' A' ' 440' ' ' PRO . 72.5 t -85.56 126.04 40.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.169 0.509 . . . . 0.0 110.695 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -96.64 139.78 32.21 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.373 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 1.3 t -127.86 173.36 10.05 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -74.92 159.9 81.89 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.7 112.82 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.227 2.618 . . . . 0.0 111.978 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.76 -16.31 8.94 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.606 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.529 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 55.3 m-85 -112.92 146.4 39.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.875 0.338 . . . . 0.0 110.2 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.31 178.3 9.34 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 25.5 mt -74.0 147.08 85.77 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.146 0.498 . . . . 0.0 110.877 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 50.3 Cg_exo -58.41 4.2 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.486 0 C-N-CA 125.109 3.873 . . . . 0.0 115.402 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -134.69 18.2 3.57 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.484 0.183 . . . . 0.0 111.021 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 62.23 16.85 8.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -81.59 163.85 22.3 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.548 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 24.8 p -119.89 -36.37 3.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -94.66 149.82 20.85 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.538 -175.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.684 HG23 ' HD2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -145.09 139.49 22.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.726 177.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -127.0 160.33 31.42 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.523 -0.871 . . . . 0.0 113.167 -170.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 49.4 t -84.14 90.1 7.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.225 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 24.6 ptm -75.4 -50.84 14.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.206 -174.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.58 ' HA ' HE21 ' A' ' 408' ' ' GLN . 39.1 tt0 -178.83 -62.82 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -87.55 40.86 0.95 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.513 0.673 . . . . 0.0 109.355 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 97.38 -168.1 23.97 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.268 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.618 ' HA ' ' O ' ' A' ' 430' ' ' THR . 84.1 m95 -56.84 126.94 29.23 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.034 0.534 . . . . 0.0 110.162 175.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.729 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 2.9 p -69.28 -49.49 23.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -169.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.729 ' HD3' ' OG ' ' A' ' 437' ' ' SER . 8.0 Cg_exo -79.9 -20.0 9.26 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.42 2.08 . . . . 0.0 111.699 173.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 98.6 m 71.14 112.64 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.582 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.636 ' HB3' HG21 ' A' ' 414' ' ' VAL . 14.4 Cg_endo -74.38 88.97 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.582 2.188 . . . . 0.0 112.673 -175.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -144.91 105.53 4.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.628 172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 394' ' ' LEU . 3.5 p -82.51 116.34 21.9 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.459 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -94.39 152.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.322 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -74.74 113.6 12.2 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.751 0.786 . . . . 0.0 110.443 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.37 -0.85 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.13 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.977 178.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' A' ' 388' ' ' LYS . 95.3 mt . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 120.9 0.381 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER 42.81 32.9 0.43 Allowed 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 175.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -129.38 155.87 44.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.682 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.704 ' HB3' ' HA2' ' A' ' 435' ' ' GLY . 0.1 OUTLIER -154.28 111.07 3.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.563 -172.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -86.6 138.36 31.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.951 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -85.96 120.57 72.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.785 0.326 . . . . 0.0 110.397 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 -166.77 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.448 2.765 . . . . 0.0 113.225 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -128.53 96.26 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 -175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.3 mp -75.73 139.61 41.97 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.6 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.18 -36.37 58.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.257 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.606 ' OD1' ' HB2' ' A' ' 442' ' ' CYS . 19.2 p30 -109.2 28.83 8.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.045 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -134.48 159.52 23.88 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.883 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 97.4 m-85 -82.06 114.56 20.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.5 OUTLIER -96.86 47.87 1.06 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.258 -173.106 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.56 ' OE1' ' HB3' ' A' ' 398' ' ' TYR . 1.7 mp0 -73.27 13.12 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.91 0.385 . . . . 0.0 111.324 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 56.4 m-80 -131.75 5.87 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.171 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.7 t-80 -66.32 136.41 55.77 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.902 0.382 . . . . 0.0 110.934 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.26 -4.34 73.79 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.782 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 71.9 mtt85 -89.53 144.44 26.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.021 0.439 . . . . 0.0 110.594 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -112.56 135.36 53.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.75 -179.55 4.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.665 -176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.93 153.09 38.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.224 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.525 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -50.29 126.8 15.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.873 0.368 . . . . 0.0 110.602 178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.67 -21.4 21.2 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.898 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.925 ' HA ' ' HE2' ' A' ' 410' ' ' LYS . 8.9 mmpt? -79.27 153.14 30.12 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.177 0.513 . . . . 0.0 111.271 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.491 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -133.74 167.34 20.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.59 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.7 tp -167.47 137.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.996 0.427 . . . . 0.0 110.382 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 7.8 p-10 -83.93 134.6 34.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.67 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 47.2 t -87.43 127.74 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.126 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -97.95 81.88 2.91 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.646 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 60.7 m -75.18 146.63 41.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.469 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 11.1 m170 -68.7 164.19 48.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.84 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 47.1 Cg_exo -57.09 123.34 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.037 2.492 . . . . 0.0 111.981 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 104.26 -16.17 49.66 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.223 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.499 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 90.0 m-85 -108.87 149.18 29.51 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.718 -0.284 . . . . 0.0 110.966 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -155.06 163.06 40.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.138 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 49.5 mt -70.91 146.57 93.26 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.622 0.249 . . . . 0.0 110.998 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.71 ' HA ' HD11 ' A' ' 443' ' ' ILE . 35.9 Cg_exo -42.99 -52.46 4.72 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 C-N-CA 124.489 3.459 . . . . 0.0 114.166 -174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.63 28.93 1.21 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.791 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.86 34.4 24.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.401 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -101.65 166.62 10.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.446 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 2.4 p -121.19 3.93 10.36 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -138.77 156.73 47.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.698 -172.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 4.6 p -142.72 135.77 26.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.3 p -125.94 163.94 21.89 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.511 -174.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 435' ' ' GLY . 21.7 t -96.32 97.22 9.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.778 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 26.4 ptm -78.75 -32.57 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.921 0.391 . . . . 0.0 111.522 -175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.525 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -176.03 -77.02 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -178.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.35 19.95 1.42 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.575 -171.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.704 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 120.4 -157.27 15.8 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.52 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.714 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 57.8 m95 -65.94 127.44 32.05 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.542 0.737 . . . . 0.0 111.502 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.691 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 38.7 t -86.66 -54.31 0.39 Allowed Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.344 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.8 Cg_exo -57.93 -21.14 48.02 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 121.961 1.774 . . . . 0.0 111.664 177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 34.3 m 70.62 103.57 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.425 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.489 ' HD3' HG21 ' A' ' 429' ' ' VAL . 23.5 Cg_endo -72.07 92.01 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.399 2.066 . . . . 0.0 112.348 -176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.572 ' O ' ' HD3' ' A' ' 423' ' ' PRO . 58.9 mtp180 -143.91 119.22 10.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.143 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.606 ' HB2' ' OD1' ' A' ' 396' ' ' ASN . 86.1 m -90.77 103.22 15.95 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.131 0.491 . . . . 0.0 110.726 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 423' ' ' PRO . 12.0 pt -95.49 143.88 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.774 173.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 420' ' ' TYR . 31.8 ttp-105 -67.45 119.85 12.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -101.24 -11.72 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.671 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt . . . . . 0 C--O 1.245 0.844 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.24 179.592 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 121.229 0.538 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -76.39 91.11 3.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.448 172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -70.51 152.24 44.21 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.236 0.541 . . . . 0.0 110.144 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.9 m -126.91 101.99 6.81 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.194 -170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.59 136.44 42.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.242 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -89.15 118.18 68.93 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.19 -176.49 3.23 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.958 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -109.69 118.24 36.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.668 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.7 55.16 0.95 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.233 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 59.57 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.115 0.566 . . . . 0.0 112.055 175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.579 ' HB2' ' ND1' ' A' ' 417' ' ' HIS . 77.4 m-20 -120.37 17.19 12.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.887 0.375 . . . . 0.0 110.415 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -64.93 167.66 30.11 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -82.09 -25.8 34.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 117.502 0.651 . . . . 0.0 111.439 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 402' ' ' HIS . 1.2 p30 34.41 71.38 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 401' ' ' ASN . 9.5 pt20 -57.57 -13.21 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.078 174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 400' ' ' GLN . 26.8 m-80 -136.62 22.61 3.14 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 399' ' ' ASN . 17.1 t-80 -55.18 132.76 48.32 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.305 0.502 . . . . 0.0 111.531 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 92.94 1.44 67.49 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.58 172.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -102.07 157.67 16.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.091 0.472 . . . . 0.0 111.284 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -119.25 114.18 22.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.092 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -97.04 171.61 8.37 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.109 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.1 tt0 -45.77 124.98 5.64 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.766 0.426 . . . . 0.0 111.253 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.8 -21.06 21.49 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.187 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.826 ' HE3' ' HA ' ' A' ' 410' ' ' LYS . 0.0 OUTLIER -72.15 143.16 49.04 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.437 0.637 . . . . 0.0 112.042 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 430' ' ' THR . 43.8 t -119.39 166.18 13.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.585 175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -176.49 138.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.67 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -82.38 129.61 34.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.403 0.62 . . . . 0.0 111.669 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 422' ' ' LEU . 21.2 t -86.4 115.79 28.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.288 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.85 87.4 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.162 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 13.1 m -77.39 142.23 39.39 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.367 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.676 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -58.75 149.06 65.59 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.419 175.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.76 120.73 5.63 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 124.062 3.174 . . . . 0.0 112.968 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 103.49 -7.23 50.38 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.533 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.77 141.78 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.706 0.288 . . . . 0.0 111.022 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.38 160.28 43.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 414' ' ' VAL . 34.7 mt -70.82 141.51 87.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.526 0.679 . . . . 0.0 111.676 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.62 ' HA ' HD11 ' A' ' 443' ' ' ILE . 50.8 Cg_exo -57.14 -11.84 8.67 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 125.131 3.888 . . . . 0.0 115.004 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' A' ' 438' ' ' PRO . 44.8 mtmt -117.05 22.29 12.66 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.04 39.9 30.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.994 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -102.0 152.14 21.31 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.414 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.3 p -113.79 2.81 15.27 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -137.77 156.89 47.49 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.34 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 1.039 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.3 p -139.54 137.27 40.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.065 0.459 . . . . 0.0 110.047 174.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -133.22 153.95 51.08 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.135 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 16.9 t -88.87 113.52 24.5 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.812 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.632 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 22.1 ptm -86.23 -40.29 15.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.543 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 32.1 tt0 -168.48 -70.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.663 0.268 . . . . 0.0 110.341 -177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -83.95 -14.32 51.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.317 0.58 . . . . 0.0 110.13 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 164.57 -157.43 29.81 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.823 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.739 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 71.7 m95 -63.66 129.08 38.67 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.321 0.649 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.632 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 4.5 p -84.39 -41.02 0.71 Allowed Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 1.039 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 39.0 Cg_exo -64.77 -17.44 59.5 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.976 1.784 . . . . 0.0 111.661 171.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 16.4 m 62.5 96.66 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 27.9 Cg_endo -69.79 86.0 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.971 2.447 . . . . 0.0 112.545 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -151.05 87.1 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.886 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 31.0 m -68.57 109.73 3.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.351 -174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 423' ' ' PRO . 9.5 pt -81.91 156.52 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.566 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -76.27 124.58 27.71 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.367 0.603 . . . . 0.0 111.227 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.12 -19.66 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.684 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.358 -0.829 . . . . 0.0 109.714 176.54 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 17.9 mmt180 -86.09 99.0 11.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.929 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 148.76 29.77 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 168.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 3.3 m -127.91 112.01 14.22 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.094 -168.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.413 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 85.7 t80 -76.48 133.93 39.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.447 177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -89.51 119.19 69.57 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.22 -170.52 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.602 2.868 . . . . 0.0 113.601 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.445 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 71.1 t80 -118.81 119.88 35.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.034 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.752 HD21 ' HA ' ' A' ' 441' ' ' ARG . 71.0 mt -96.74 135.12 39.13 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.105 174.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -78.23 -23.21 47.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.429 -175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -106.7 11.08 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.117 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.96 172.99 16.06 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.779 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -88.15 -30.64 19.65 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.63 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 44.3 m-80 72.83 -63.74 0.42 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.385 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.63 ' HG2' ' O ' ' A' ' 399' ' ' ASN . 2.4 pt20 56.33 -41.26 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.498 1.919 . . . . 0.0 114.159 -177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 91.0 m-20 -98.7 16.12 23.1 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.244 0.545 . . . . 0.0 110.185 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 12.5 t-80 -56.82 123.41 14.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.688 176.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.413 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 99.0 -9.89 61.78 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.03 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.512 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 37.2 mtt180 -83.84 146.88 27.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.106 0.479 . . . . 0.0 111.136 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -110.39 121.63 45.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -105.76 -170.02 1.67 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.463 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 410' ' ' LYS . 9.8 p -142.31 158.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.822 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 4.1 tp60 -43.31 122.16 2.47 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 124.081 0.863 . . . . 0.0 111.528 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 97.06 -12.98 65.35 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.89 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 407' ' ' VAL . 17.8 mttp -84.16 157.21 21.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 117.504 0.652 . . . . 0.0 110.561 176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.8 t -129.38 169.94 14.28 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.371 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.7 tp -172.67 135.93 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.143 0.497 . . . . 0.0 110.906 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.642 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 6.6 p-10 -83.14 126.65 32.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.64 122.93 38.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.488 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.35 109.8 17.6 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.607 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 76.8 m -125.61 168.04 14.26 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.683 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -73.01 160.34 83.13 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.58 119.33 6.49 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.526 2.817 . . . . 0.0 111.672 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.57 33.69 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.585 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.638 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 79.8 m-85 -101.32 140.72 35.22 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 120.878 0.37 . . . . 0.0 110.349 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -161.63 173.38 14.81 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.693 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.753 ' HB2' ' HB2' ' A' ' 426' ' ' GLN . 50.2 mt -77.72 154.45 80.99 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 424' ' ' LYS . 66.5 Cg_exo -45.59 131.01 12.45 Favored 'Trans proline' 0 C--N 1.33 -0.404 0 C-N-CA 123.964 3.109 . . . . 0.0 112.279 177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 423' ' ' PRO . 35.0 mmtp 72.47 30.55 1.92 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.471 -174.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.55 47.37 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.635 176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.753 ' HB2' ' HB2' ' A' ' 422' ' ' LEU . 83.1 mm-40 -91.62 150.29 21.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.141 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 4.5 p -118.55 -7.51 10.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.589 0.709 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.1 OUTLIER -130.24 152.42 49.68 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.348 -173.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.955 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.5 p -138.15 135.16 44.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -125.45 162.74 24.17 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.018 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.53 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 4.4 t -97.32 111.71 23.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.987 0.422 . . . . 0.0 111.061 -174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -99.83 -162.62 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.402 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 35.2 tt0 -50.46 -53.42 29.84 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -169.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -96.86 25.51 5.24 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.836 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.53 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 105.73 -164.45 13.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.597 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.651 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 63.3 m95 -45.62 118.37 1.77 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.274 0.629 . . . . 0.0 111.099 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.554 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 25.8 t -78.01 -51.08 1.75 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.407 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.955 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 51.4 Cg_exo -58.75 -17.06 34.08 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.959 1.772 . . . . 0.0 112.376 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 27.7 m 65.77 97.89 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.725 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 62.5 Cg_endo -71.4 79.24 1.49 Allowed 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 123.086 2.524 . . . . 0.0 113.138 -170.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.752 ' HA ' HD21 ' A' ' 394' ' ' LEU . 7.5 ptm180 -144.4 124.06 13.31 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.564 171.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.696 ' H ' HD13 ' A' ' 394' ' ' LEU . 86.9 m -87.85 132.44 34.19 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.371 0.605 . . . . 0.0 110.852 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 3.8 pt -114.14 148.86 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.421 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 41.6 ttm180 -76.88 109.35 10.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.475 0.655 . . . . 0.0 109.567 177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.36 -32.36 50.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.266 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 C--O 1.248 0.986 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.143 175.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 388' ' ' LYS . 10.1 mp . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.651 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.1 OUTLIER -40.1 80.88 0.0 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.838 1.255 . . . . 0.0 113.859 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 386' ' ' LEU . 7.2 ttpm? -174.14 162.8 3.8 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 174.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 1.0 OUTLIER -155.17 132.74 11.22 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.974 0.416 . . . . 0.0 110.883 -176.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 49.5 t80 -110.61 125.6 53.58 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.654 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -80.98 108.83 11.24 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 94.0 Cg_endo -81.54 -176.94 3.32 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 123.416 2.744 . . . . 0.0 113.155 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -95.44 99.92 11.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.324 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 394' ' ' LEU . 6.5 mp -73.19 129.74 38.71 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -48.08 -61.1 2.14 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.666 0.603 . . . . 0.0 111.821 -172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -112.56 50.96 0.84 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.206 0.526 . . . . 0.0 110.996 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -124.96 161.12 19.55 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.46 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -77.77 -26.93 50.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.074 0.437 . . . . 0.0 110.677 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.7 m-20 45.44 62.55 2.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.871 0.732 . . . . 0.0 111.428 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.603 ' HG3' ' OD1' ' A' ' 401' ' ' ASN . 7.8 pt20 -66.1 -6.28 12.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.603 ' OD1' ' HG3' ' A' ' 400' ' ' GLN . 8.5 m120 -126.27 19.48 7.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.554 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 19.4 t-80 -53.67 126.73 22.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.942 0.401 . . . . 0.0 111.857 -178.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 83.2 17.28 67.29 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.005 173.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.34 159.71 16.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.748 0.308 . . . . 0.0 110.822 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.75 149.07 42.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.172 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.892 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 97.5 m-85 -135.15 -178.68 5.21 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.191 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 8.0 p -120.19 157.66 22.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.698 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 7.6 tt0 -53.15 123.0 10.57 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.407 . . . . 0.0 110.147 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 114.71 -20.62 14.95 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.997 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 410' ' ' LYS . 28.5 mmtp -77.5 148.25 35.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.244 0.545 . . . . 0.0 111.393 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.49 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.7 t -131.63 166.0 22.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.898 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -168.97 137.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.107 0.479 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 13.7 p-10 -90.62 113.71 25.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.98 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 429' ' ' VAL . 85.0 t -80.05 127.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.698 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -88.21 100.47 13.0 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.466 177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 85.1 m -95.81 156.36 16.36 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.424 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -65.36 164.01 27.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.719 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.2 117.28 4.01 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.314 2.676 . . . . 0.0 111.612 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 109.59 -15.21 32.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 88.1 m-85 -106.89 150.62 26.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.837 0.351 . . . . 0.0 110.566 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -150.82 177.4 10.15 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 414' ' ' VAL . 68.0 mt -92.84 149.37 37.65 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 120.866 0.365 . . . . 0.0 110.058 175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 443' ' ' ILE . 92.4 Cg_exo -47.65 140.21 17.26 Favored 'Trans proline' 0 C--N 1.332 -0.291 0 C-N-CA 124.056 3.17 . . . . 0.0 112.485 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp 68.59 29.75 5.37 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.084 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.85 43.78 24.35 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.595 177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -96.34 160.42 14.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.912 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.4 p -124.19 4.97 8.52 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -137.93 151.62 48.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.18 -171.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.874 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.6 p -141.73 141.89 29.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 4.9 p -133.4 157.29 45.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.865 -0.734 . . . . 0.0 112.746 -173.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.64 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 4.0 m -83.6 95.69 8.42 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.01 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.676 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 26.2 ptm -82.49 -40.96 20.35 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -174.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.698 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 5.0 tp10 -169.51 -70.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -86.64 25.58 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.859 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 389' ' ' CYS . . . 109.1 -143.11 16.31 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.951 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.64 ' CZ3' ' SG ' ' A' ' 431' ' ' CYS . 18.7 m95 -64.84 134.54 54.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.275 0.63 . . . . 0.0 111.962 -175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.789 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 26.2 t -89.67 -57.27 0.26 Allowed Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.019 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.874 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 22.7 Cg_exo -65.7 -20.62 59.35 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.08 1.854 . . . . 0.0 111.527 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.4 m 72.63 116.32 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.858 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 13.7 Cg_endo -76.78 90.77 1.2 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.464 2.11 . . . . 0.0 111.645 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -139.7 107.29 5.6 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.056 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 77.5 m -68.93 84.16 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.289 0.368 . . . . 0.0 110.025 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.3 pt -86.09 141.07 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.789 177.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -68.56 114.86 7.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.376 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.7 p -79.01 -10.33 12.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.016 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.248 1.007 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.185 174.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.735 HD22 ' HA ' ' A' ' 434' ' ' ASN . 9.3 mp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? 59.42 31.11 20.84 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 121.604 0.716 . . . . 0.0 112.525 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 388' ' ' LYS . 3.9 mppt? -145.94 173.97 11.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.986 176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.926 ' SG ' ' HB2' ' A' ' 406' ' ' PHE . 2.1 p -154.99 123.12 5.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.044 0.45 . . . . 0.0 110.525 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -110.18 123.26 49.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.492 ' HE2' ' HA ' ' A' ' 399' ' ' ASN . 16.6 t80 -74.75 112.72 18.89 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.44 -174.27 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.026 2.484 . . . . 0.0 113.043 -171.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.443 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 46.7 t80 -103.21 96.07 6.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.615 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 442' ' ' CYS . 8.4 mp -78.97 119.67 22.46 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.317 174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -64.23 -30.68 71.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.314 0.578 . . . . 0.0 109.829 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 442' ' ' CYS . 78.5 m-20 -94.58 16.89 14.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.989 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -138.5 174.64 21.9 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.847 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -89.2 -29.35 19.34 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.369 0.268 . . . . 0.0 110.309 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 402' ' ' HIS . 15.1 m-80 52.84 66.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.7 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -49.76 -34.61 19.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.096 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 391' ' ' PHE . 41.0 m-80 -113.13 28.23 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.24 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.518 ' HB2' ' CB ' ' A' ' 399' ' ' ASN . 15.4 t-80 -57.64 123.86 17.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.219 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 89.91 5.72 70.6 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -98.22 134.86 40.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.391 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -100.82 135.17 42.69 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.977 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.926 ' HB2' ' SG ' ' A' ' 389' ' ' CYS . 98.0 m-85 -124.67 171.48 10.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.631 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.88 152.8 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.698 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 33.8 tt0 -51.93 127.69 21.94 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.798 0.332 . . . . 0.0 110.444 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.53 -14.21 27.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.083 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -86.57 163.91 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.902 0.382 . . . . 0.0 111.442 178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.6 t -137.47 168.39 19.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.492 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 11.3 tp -174.49 146.63 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.712 0.291 . . . . 0.0 110.808 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 12.3 p-10 -87.49 142.25 28.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 111.922 -174.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 41.4 t -99.82 139.24 21.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.453 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -123.56 109.71 14.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.109 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.566 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 58.6 m -97.77 166.44 11.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -78.04 159.89 74.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.29 114.58 2.04 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.49 2.793 . . . . 0.0 112.522 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 446' ' ' LYS . . . 117.02 -21.89 10.79 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 67.5 m-85 -109.73 150.34 28.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -160.68 176.82 11.11 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 71.0 mt -80.5 148.54 66.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 120.939 0.4 . . . . 0.0 110.342 175.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.567 ' HA ' HD11 ' A' ' 443' ' ' ILE . 57.6 Cg_exo -41.98 -60.52 0.67 Allowed 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 124.673 3.582 . . . . 0.0 114.466 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -89.21 33.31 0.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.554 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.3 39.48 30.16 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.948 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -89.92 161.18 16.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.053 -176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 10.1 p -119.95 -0.98 10.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.171 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -141.91 159.75 41.6 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.355 -168.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.912 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.9 p -145.91 140.8 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 5.6 p -127.42 165.17 20.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 119.463 -0.895 . . . . 0.0 112.776 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.605 ' SG ' ' CZ3' ' A' ' 436' ' ' TRP . 8.8 m -89.72 102.92 15.61 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.683 -175.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.66 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 19.5 ptm -94.31 -157.6 0.57 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.698 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 18.6 tt0 -58.2 -60.4 3.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.093 0.473 . . . . 0.0 110.895 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . 0.735 ' HA ' HD22 ' A' ' 386' ' ' LEU . 1.8 m120 -84.81 46.09 1.22 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.629 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 71.0 -143.1 35.66 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.035 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.634 ' HA ' ' O ' ' A' ' 430' ' ' THR . 16.4 m95 -53.49 121.24 7.31 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 122.622 0.369 . . . . 0.0 111.502 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 0.4 OUTLIER -79.67 -50.43 1.26 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.34 -176.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.912 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 31.8 Cg_exo -62.23 -26.68 77.7 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.833 1.689 . . . . 0.0 111.193 172.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 39.7 m 67.49 109.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.217 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.522 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 9.7 Cg_endo -74.98 98.36 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.314 2.009 . . . . 0.0 111.457 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -145.07 103.66 3.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.603 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 396' ' ' ASN . 61.8 m -75.44 97.4 3.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.897 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 423' ' ' PRO . 14.1 pt -88.86 152.02 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.837 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.3 116.59 16.2 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 121.641 0.734 . . . . 0.0 110.838 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.439 HG13 ' HG3' ' A' ' 446' ' ' LYS . 9.9 p -107.34 -17.55 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.988 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.541 ' HB2' ' HA2' ' A' ' 419' ' ' GLY . 8.0 mtpm? . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.736 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.592 ' HB2' ' NE2' ' A' ' 408' ' ' GLN . 12.3 mmm180 -74.77 77.86 2.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.323 0.582 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 407' ' ' VAL . 97.6 mttt -74.89 171.33 14.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.659 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.564 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 85.3 m -132.05 123.3 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.226 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -84.87 135.32 34.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.52 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -80.18 116.61 62.69 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 440' ' ' PRO . 82.9 Cg_endo -78.77 -171.3 1.2 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.181 2.588 . . . . 0.0 112.761 -175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.496 ' HB2' ' NE2' ' A' ' 402' ' ' HIS . 88.7 t80 -113.99 112.69 23.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.52 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.524 HD23 ' SG ' ' A' ' 442' ' ' CYS . 6.8 mp -82.65 126.79 32.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.719 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.211 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -136.56 26.38 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -122.63 170.37 15.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.546 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -88.44 97.08 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.809 0.337 . . . . 0.0 110.261 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.2 m-80 -78.45 84.32 4.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.197 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.25 -23.9 67.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.534 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -132.3 36.98 3.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.36 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 11.3 t-80 -63.74 126.46 27.67 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.759 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.46 -14.04 64.78 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.794 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -84.86 137.39 33.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.264 0.554 . . . . 0.0 111.049 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -111.42 125.38 53.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.492 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.972 ' HB3' ' HG2' ' A' ' 410' ' ' LYS . 98.0 m-85 -114.57 149.88 35.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.824 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.457 ' HA ' ' HG2' ' A' ' 388' ' ' LYS . 7.5 p -54.98 169.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.439 173.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' A' ' 387' ' ' ARG . 35.6 tt0 -80.83 133.59 35.63 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.65 -27.04 7.38 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.202 -0.999 . . . . 0.0 113.284 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.972 ' HG2' ' HB3' ' A' ' 406' ' ' PHE . 0.0 OUTLIER -70.01 171.14 9.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.964 0.888 . . . . 0.0 112.774 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.446 ' OG ' HG22 ' A' ' 430' ' ' THR . 34.9 t -140.42 156.2 46.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 109.121 173.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.3 tp -156.31 136.82 4.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.542 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 3.1 p-10 -82.78 137.11 34.47 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 73.5 t -113.03 121.44 65.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.154 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -104.96 122.94 46.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.744 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 420' ' ' TYR . 3.4 t -100.32 -177.68 3.58 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 53.0 m80 -77.29 166.28 45.5 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 52.3 Cg_exo -54.64 113.03 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 123.051 2.501 . . . . 0.0 113.262 -175.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 106.17 4.03 38.49 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.953 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.501 ' HB2' ' SG ' ' A' ' 416' ' ' CYS . 84.0 m-85 -122.19 138.57 54.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.0 0.4 . . . . 0.0 110.001 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.14 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.574 0.226 . . . . 0.0 110.696 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 63.5 mt -72.43 144.64 86.84 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.336 0.589 . . . . 0.0 111.943 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.49 ' HA ' HD11 ' A' ' 443' ' ' ILE . 48.9 Cg_exo -59.52 -0.5 0.75 Allowed 'Trans proline' 0 N--CA 1.477 0.534 1 C-N-CA 125.342 4.028 . . . . 0.0 115.184 -177.325 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -126.55 26.92 6.22 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.813 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 55.86 29.0 13.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.107 0.48 . . . . 0.0 110.989 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -102.44 165.63 10.99 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.423 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 7.4 p -125.28 -2.53 7.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -127.64 149.1 50.34 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.324 -175.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.814 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.1 p -135.03 134.83 53.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.0 p -127.62 161.69 28.25 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 120.158 -0.617 . . . . 0.0 112.154 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 410' ' ' LYS . 29.4 t -91.4 99.59 12.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.911 -176.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 18.8 ptt? -90.52 -162.38 0.9 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.539 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 33.7 tt0 -65.6 -49.26 69.4 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.22 0.533 . . . . 0.0 110.912 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -93.81 36.23 1.11 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.375 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 97.58 -165.61 22.46 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.266 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.767 ' CH2' ' HE2' ' A' ' 410' ' ' LYS . 79.1 m95 -54.17 117.14 3.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.73 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 30.4 t -68.67 -52.67 18.12 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.464 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.814 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.9 Cg_exo -68.68 -29.38 29.66 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.027 1.818 . . . . 0.0 111.53 169.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.582 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 37.4 m 66.42 121.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.585 -173.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 15.9 Cg_exo -64.94 89.64 0.19 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.79 2.326 . . . . 0.0 111.736 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 439' ' ' THR . 21.5 ptt180 -152.25 91.12 1.57 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.524 ' SG ' HD23 ' A' ' 394' ' ' LEU . 18.9 p -83.29 105.6 14.38 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.594 0.711 . . . . 0.0 110.68 -177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.6 pt -88.75 161.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.767 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -75.9 109.63 9.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.172 0.987 . . . . 0.0 111.961 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 99.4 t -83.93 -47.47 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 113.236 -1.802 . . . . 0.0 109.07 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.244 0.809 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.96 178.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.426 -1.668 0 CA-C-O 122.81 1.29 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.486 ' HA ' ' HE ' ' A' ' 387' ' ' ARG . 3.4 mmp_? -118.36 81.98 1.77 Allowed 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 112.671 -2.059 . . . . 0.0 110.585 -176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.451 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 1.1 mptp? -70.19 134.46 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.603 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 67.3 m -103.24 104.92 15.1 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.746 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 392' ' ' PRO . 88.0 t80 -68.8 129.25 39.38 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 172.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -76.21 106.04 2.83 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 390' ' ' TYR . 48.6 Cg_endo -67.37 151.47 80.41 Favored 'Trans proline' 0 CA--C 1.513 -0.537 0 C-N-CA 123.0 2.467 . . . . 0.0 111.852 -172.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.55 ' HA ' ' CD2' ' A' ' 402' ' ' HIS . 53.9 t80 -75.82 125.64 29.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.359 0.599 . . . . 0.0 111.653 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.27 101.73 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.473 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -61.86 -27.39 68.76 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.56 0.695 . . . . 0.0 109.724 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -93.49 10.66 31.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.544 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -139.27 165.04 25.82 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.93 -176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 415' ' ' ALA . 87.4 m-85 -80.13 170.42 16.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.193 0.521 . . . . 0.0 110.32 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 1.089 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 0.1 OUTLIER -126.94 79.84 1.91 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.609 -176.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -73.53 -39.87 64.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.357 0.599 . . . . 0.0 109.66 173.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -140.7 45.49 1.81 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.249 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 1.089 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 0.2 OUTLIER -82.6 144.08 30.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.687 -177.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 82.62 17.07 69.17 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.737 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -118.55 158.99 24.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.519 0.2 . . . . 0.0 110.761 -175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -118.44 127.8 54.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.973 0.416 . . . . 0.0 110.585 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.23 136.01 50.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.978 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.33 150.72 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.86 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.682 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 34.9 tt0 -52.76 122.48 9.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.771 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.71 9.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.519 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -86.48 166.02 15.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.172 0.51 . . . . 0.0 112.153 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.506 ' CB ' HG22 ' A' ' 430' ' ' THR . 39.5 t -132.47 173.53 11.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.25 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.3 tp 179.95 127.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.418 0.628 . . . . 0.0 110.814 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.796 ' HA ' ' HB ' ' A' ' 428' ' ' THR . 8.0 p-10 -67.9 139.41 56.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.458 -173.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 43.7 t -100.01 128.78 51.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.315 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 398' ' ' TYR . . . -105.65 101.43 10.95 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.5 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.45 151.53 26.52 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 420' ' ' TYR . 68.2 m170 -70.8 164.97 51.14 Favored Pre-proline 0 C--N 1.331 -0.203 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.83 121.18 9.3 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.8 2.333 . . . . 0.0 111.517 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.47 0.17 53.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.029 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.46 ' CD2' ' HB2' ' A' ' 417' ' ' HIS . 90.8 m-85 -119.84 153.92 35.07 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -158.1 156.28 30.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.057 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 37.2 mt -78.25 137.33 60.45 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.876 0.846 . . . . 0.0 110.523 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 84.5 Cg_exo -51.38 -38.94 63.99 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 125.143 3.896 . . . . 0.0 113.935 -174.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -98.45 25.27 6.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.684 -174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.15 39.5 29.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 438' ' ' PRO . 31.9 mm-40 -101.82 157.74 16.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.1 p -114.89 5.71 15.2 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.796 ' HB ' ' HA ' ' A' ' 413' ' ' ASP . 2.7 t -159.15 -176.78 6.03 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.676 -177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.927 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.1 p -158.65 144.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.885 -176.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.8 p -129.09 155.48 45.38 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 120.279 -0.569 . . . . 0.0 112.07 -176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 408' ' ' GLN . 49.9 t -87.58 101.22 13.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.883 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 13.0 ptm -91.06 -167.11 1.73 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 174.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.682 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 27.3 tt0 -61.86 -50.9 70.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 110.821 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -87.32 31.6 0.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.182 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.622 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 93.49 -163.94 26.52 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.133 174.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.708 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 82.1 m95 -51.79 116.71 2.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.141 0.496 . . . . 0.0 110.463 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 17.0 t -72.69 -55.66 4.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.315 -171.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.927 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 49.7 Cg_exo -58.34 -28.46 84.84 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.097 1.865 . . . . 0.0 111.341 173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 31.6 m 73.21 107.23 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.482 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 59.1 Cg_endo -79.46 96.2 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.848 2.366 . . . . 0.0 112.638 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -155.07 95.9 1.78 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.004 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 75.5 m -71.45 101.14 2.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.954 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 24.7 pt -75.04 152.8 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.039 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.44 ' HE ' ' C ' ' A' ' 446' ' ' LYS . 52.0 ttt180 -87.21 125.6 34.28 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.466 0.65 . . . . 0.0 111.091 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 6.3 p -108.58 -13.51 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.911 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 446' ' ' LYS . 55.5 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.622 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -79.73 88.81 5.18 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.588 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -68.06 146.14 53.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.79 110.7 18.74 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.984 -168.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -84.9 126.35 33.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.81 ' HZ ' HG22 ' A' ' 414' ' ' VAL . 1.6 t80 -81.3 129.31 67.04 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -90.9 151.87 3.98 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.317 2.678 . . . . 0.0 113.861 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 25.4 t80 -71.42 96.17 1.45 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.563 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 440' ' ' PRO . 10.0 mp -65.81 131.29 45.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.845 171.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 395' ' ' GLU . 1.4 mp0 -59.84 -37.84 80.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.098 -171.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -111.65 27.12 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.041 0.448 . . . . 0.0 111.399 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -113.41 173.07 14.8 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.768 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -81.84 -31.69 31.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.478 0.656 . . . . 0.0 110.641 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 55.86 35.86 26.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.95 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -62.69 -16.77 58.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.419 0.628 . . . . 0.0 109.821 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -113.27 13.27 19.11 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.157 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.454 ' ND1' ' O ' ' A' ' 391' ' ' PHE . 68.4 t60 -82.52 153.63 25.47 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.971 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 91.39 -4.69 80.43 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.941 -174.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -98.97 158.72 15.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.943 0.401 . . . . 0.0 110.947 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -123.56 129.99 52.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.019 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.86 174.11 6.03 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.747 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.32 141.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.639 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.1 tt0 -50.28 113.75 0.95 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.708 0.63 . . . . 0.0 110.747 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 126.3 -19.56 6.35 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.145 -175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -92.53 168.55 11.18 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.33 0.586 . . . . 0.0 111.736 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.548 ' OG ' HG22 ' A' ' 430' ' ' THR . 38.8 t -130.08 166.65 19.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.803 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 9.8 tp -160.5 141.97 4.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.432 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.4 p-10 -88.09 133.98 33.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.71 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.81 HG22 ' HZ ' ' A' ' 391' ' ' PHE . 59.8 t -96.58 122.82 48.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.762 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -95.92 91.97 6.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.693 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.58 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 88.8 m -85.38 156.79 20.72 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 173.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -69.45 158.63 86.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.142 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.88 113.45 1.57 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.513 2.808 . . . . 0.0 111.823 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.34 8.79 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.689 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 97.2 m-85 -120.76 145.64 47.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -154.39 -172.81 4.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.225 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 58.1 mt -94.07 149.93 37.64 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.389 0.614 . . . . 0.0 110.854 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.455 ' HA ' HD11 ' A' ' 443' ' ' ILE . 77.0 Cg_exo -53.87 146.62 45.4 Favored 'Trans proline' 0 C--N 1.331 -0.353 0 C-N-CA 124.233 3.289 . . . . 0.0 112.835 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 62.01 36.74 15.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.675 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 57.51 27.99 14.86 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.182 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 16.2 mm100 -84.49 159.73 20.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.99 0.49 3.85 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.3 OUTLIER -132.62 151.73 51.86 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.025 -173.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.93 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 7.6 p -141.37 132.66 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 2.6 p -117.29 162.94 17.09 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.681 -174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 15.7 t -96.03 105.88 17.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.901 -176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 22.6 ptm -89.81 -157.46 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.639 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.7 tp10 -53.62 -59.42 4.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.945 0.402 . . . . 0.0 111.592 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -77.99 -11.94 59.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.36 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 127.88 -150.46 18.34 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.803 -177.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.672 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 45.9 m95 -51.71 110.1 0.43 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.062 0.458 . . . . 0.0 111.236 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.581 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 37.5 t -75.39 -51.51 3.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.975 -173.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.93 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 50.0 Cg_exo -57.95 -22.51 55.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.764 1.643 . . . . 0.0 111.885 172.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 20.7 m 67.72 108.22 0.03 OUTLIER Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.595 -177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.663 ' HB2' HD11 ' A' ' 394' ' ' LEU . 18.3 Cg_endo -71.28 105.51 1.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.193 1.929 . . . . 0.0 111.89 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 439' ' ' THR . 20.6 ptt180 -152.36 125.19 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.937 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 80.9 m -85.05 92.68 8.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 110.991 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 423' ' ' PRO . 25.5 pt -85.75 139.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-O 121.07 0.462 . . . . 0.0 109.902 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 38.5 ttt180 -70.98 122.58 20.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.964 0.887 . . . . 0.0 110.906 -178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 93.4 t -72.25 -44.85 63.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.847 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 446' ' ' LYS . 18.7 ptmt . . . . . 0 C--O 1.249 1.07 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.358 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 110.761 -0.089 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.55 86.67 6.32 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.278 -175.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -73.46 149.33 42.45 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 163.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 4.1 m -122.92 117.66 26.07 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.427 -170.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -84.53 133.2 34.46 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.322 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -86.77 131.89 43.93 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.611 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -89.98 145.46 4.47 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.249 2.633 . . . . 0.0 113.892 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.489 ' HB2' ' CD2' ' A' ' 402' ' ' HIS . 35.2 t80 -67.17 124.49 23.23 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.071 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.601 HD23 ' SG ' ' A' ' 416' ' ' CYS . 7.7 mp -95.14 114.31 26.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -63.53 127.47 31.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.571 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 417' ' ' HIS . 38.6 m-20 72.7 -9.74 1.04 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.921 0.888 . . . . 0.0 111.33 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.85 -173.79 34.81 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.624 -173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -88.48 97.16 10.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.113 0.482 . . . . 0.0 111.033 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.3 OUTLIER -98.46 47.01 0.99 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.775 176.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -61.9 -16.84 53.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.205 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.536 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 86.1 m-20 -119.37 -0.62 10.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.489 ' CD2' ' HB2' ' A' ' 393' ' ' TYR . 80.0 t60 -71.32 151.28 44.31 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.362 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.66 74.87 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.046 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.536 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 85.5 mtt180 -98.45 152.84 19.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.909 0.385 . . . . 0.0 111.267 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -119.14 126.64 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.19 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -107.86 177.95 4.66 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 10.9 p -110.16 147.32 14.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.534 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.2 tt0 -51.72 113.96 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.674 0.609 . . . . 0.0 110.387 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 119.4 -13.5 11.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.624 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -90.13 155.44 19.05 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.291 0.546 . . . . 0.0 111.676 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.485 ' CB ' HG22 ' A' ' 430' ' ' THR . 44.5 t -123.68 165.87 16.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.242 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.9 tp -171.47 135.48 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 10.8 m-20 -79.36 125.41 29.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.177 0.513 . . . . 0.0 109.963 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 440' ' ' PRO . 71.2 t -114.77 107.97 24.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.488 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -94.72 135.84 35.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.969 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 394' ' ' LEU . 0.1 OUTLIER -103.09 175.44 5.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.875 177.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.775 ' CD2' ' H ' ' A' ' 417' ' ' HIS . 0.0 OUTLIER -55.32 149.13 28.54 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.08 176.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -47.06 120.43 4.22 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.507 2.805 . . . . 0.0 112.8 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 105.48 -12.67 47.36 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.964 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.482 ' HB3' ' SG ' ' A' ' 442' ' ' CYS . 98.7 m-85 -115.44 136.25 53.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.515 0.198 . . . . 0.0 110.652 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.99 177.7 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.962 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 76.3 mt -80.63 147.94 64.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.206 0.527 . . . . 0.0 111.004 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.674 ' HA ' HD11 ' A' ' 443' ' ' ILE . 51.2 Cg_exo -41.17 -67.53 0.12 Allowed 'Trans proline' 0 CA--C 1.521 -0.167 0 C-N-CA 124.912 3.741 . . . . 0.0 115.259 -174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -84.69 43.32 0.97 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.075 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 53.48 35.35 20.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.215 0.531 . . . . 0.0 111.515 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 15.1 mm100 -103.01 155.24 18.51 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.389 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 9.8 p -109.64 -7.06 15.15 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.66 176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.663 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -124.27 157.04 35.84 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.395 0.617 . . . . 0.0 111.643 -168.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.83 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 0.2 OUTLIER -144.84 138.75 22.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.993 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.2 p -125.19 153.74 42.63 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.27 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 15.9 t -86.29 105.94 17.01 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 433' ' ' GLU . 17.1 ptm -91.48 -163.64 1.07 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.534 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 37.5 tt0 -56.3 -50.87 70.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.877 0.37 . . . . 0.0 111.228 -176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -97.68 46.25 1.02 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 111.265 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 88.29 -174.11 43.23 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.348 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.564 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 73.5 m95 -48.87 114.79 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.636 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 16.3 t -69.95 -55.36 8.68 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.518 -174.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.83 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.5 Cg_exo -66.61 -29.06 44.23 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.598 1.532 . . . . 0.0 111.107 172.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.569 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 86.6 m 71.11 123.57 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.126 -177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.494 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.9 Cg_exo -65.62 92.75 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.651 2.234 . . . . 0.0 111.373 176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 439' ' ' THR . 14.3 ptt180 -149.88 -169.61 3.42 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 420' ' ' TYR . 26.7 p -167.35 135.15 2.45 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.332 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 423' ' ' PRO . 4.5 pt -108.18 153.49 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.917 171.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 420' ' ' TYR . 39.4 ttt180 -77.79 126.82 31.44 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.558 0.694 . . . . 0.0 111.225 -175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.94 12.74 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.736 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 C--O 1.248 1.018 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.971 175.524 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -89.41 82.81 6.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -87.42 149.28 24.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.294 0.569 . . . . 0.0 110.469 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 62.3 m -101.94 159.95 14.91 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.587 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.657 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 76.9 t80 -122.79 129.73 52.06 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.216 0.948 . . . . 0.0 110.051 173.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.851 ' HZ ' ' H ' ' A' ' 406' ' ' PHE . 1.8 m-85 -90.35 106.07 13.73 Favored Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.547 -165.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . 0.483 ' O ' HD12 ' A' ' 394' ' ' LEU . 71.8 Cg_endo -78.13 130.4 10.23 Favored 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.932 2.421 . . . . 0.0 112.325 -172.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -51.76 106.08 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.355 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 392' ' ' PRO . 8.0 mp -70.16 133.28 46.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.75 -20.13 43.41 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.348 -172.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -123.57 20.98 9.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.953 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -135.79 -170.48 12.08 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.052 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -109.79 112.87 25.18 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.934 0.493 . . . . 0.0 109.82 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 13.8 m-80 -95.55 84.91 4.05 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.57 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -66.85 -21.41 66.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.013 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.402 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 93.6 m-20 -129.49 40.35 3.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.445 -175.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 21.0 t-80 -71.21 140.47 50.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.389 . . . . 0.0 111.284 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.657 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 74.42 21.91 78.17 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.974 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.749 ' HB2' ' CD2' ' A' ' 391' ' ' PHE . 53.2 mtt180 -102.53 -172.98 2.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . 0.456 ' N ' ' HE2' ' A' ' 391' ' ' PHE . 66.9 mttm -139.72 126.1 20.22 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.945 0.402 . . . . 0.0 111.14 167.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.851 ' H ' ' HZ ' ' A' ' 391' ' ' PHE . 58.4 m-85 -120.12 134.65 55.2 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 14.7 p -72.88 149.59 8.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.771 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 35.1 tt0 -50.03 126.74 15.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.95 177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.76 -22.34 14.85 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.178 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -81.29 151.83 27.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.566 0.698 . . . . 0.0 111.601 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.471 ' CB ' HG22 ' A' ' 430' ' ' THR . 29.7 t -119.77 167.65 11.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.653 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -157.54 138.21 4.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.048 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.5 129.64 34.65 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.354 174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 87.4 t -96.6 119.99 45.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.608 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -96.99 136.49 37.48 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.397 177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.476 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 19.9 m -139.73 168.44 19.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.807 0.336 . . . . 0.0 111.163 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -73.28 161.59 78.45 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -57.83 119.48 6.76 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.438 2.759 . . . . 0.0 112.089 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 110.73 -16.38 28.58 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.796 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.662 ' CE2' ' HB2' ' A' ' 444' ' ' ARG . 68.3 m-85 -109.79 130.39 55.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -151.87 158.17 42.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.232 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 46.0 mt -72.65 143.0 84.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 121.37 0.605 . . . . 0.0 110.827 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 73.0 Cg_exo -51.47 138.49 47.62 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 C-N-CA 123.994 3.129 . . . . 0.0 112.252 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 71.97 28.11 2.62 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.769 0.668 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.43 34.2 22.58 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.76 175.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 22.9 mt-30 -91.29 160.81 15.32 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.889 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 19.0 p -134.58 6.47 3.5 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.403 0.62 . . . . 0.0 109.473 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.65 155.84 48.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.505 -172.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.972 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 5.8 p -147.9 141.95 19.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.288 178.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.4 p -128.4 152.92 47.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 119.682 -0.807 . . . . 0.0 113.161 -174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 30.2 t -80.47 101.42 9.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.761 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.3 ptt? -84.83 -151.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.771 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 9.2 tp10 -59.23 -53.0 63.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.948 0.404 . . . . 0.0 111.088 -178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -125.78 65.74 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.532 0.682 . . . . 0.0 110.351 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.657 ' O ' ' HG2' ' A' ' 432' ' ' MET . . . 107.9 -174.72 19.47 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.604 170.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.811 ' HZ2' ' CD1' ' A' ' 391' ' ' PHE . 71.4 m95 -59.2 124.5 20.18 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.948 0.499 . . . . 0.0 110.136 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.705 ' OG ' ' HD3' ' A' ' 438' ' ' PRO . 4.0 p -82.18 -47.39 0.95 Allowed Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -174.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.972 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 30.9 Cg_exo -65.5 -21.43 60.15 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.133 1.889 . . . . 0.0 111.666 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . . . . . . . . . 22.5 m 68.08 108.83 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.522 -174.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.801 ' HB3' HG11 ' A' ' 429' ' ' VAL . 61.4 Cg_endo -76.48 79.9 2.89 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.052 2.501 . . . . 0.0 111.938 -175.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 29.8 ptt180 -139.8 97.65 3.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.683 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 14.9 p -78.93 112.18 15.86 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.454 0.645 . . . . 0.0 110.573 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 9.5 pt -85.06 140.15 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.731 -178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.662 ' HB2' ' CE2' ' A' ' 420' ' ' TYR . 68.4 ttt180 -74.01 121.44 21.05 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 446' ' ' LYS . 13.0 p -66.55 -46.08 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.05 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 445' ' ' VAL . 42.3 tttp . . . . . 0 C--O 1.249 1.074 0 O-C-N 124.28 0.987 . . . . 0.0 109.059 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 386' ' ' LEU . 8.8 mp . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.734 ' HB2' ' OE1' ' A' ' 408' ' ' GLN . 13.8 mmt180 -87.27 91.9 8.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.358 0.599 . . . . 0.0 110.975 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 407' ' ' VAL . 34.7 mmtp -77.37 144.55 37.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.325 170.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.708 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 97.8 m -109.43 109.42 20.26 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -80.03 122.12 26.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.475 177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.473 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 14.4 t80 -68.64 125.54 91.87 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -93.36 146.14 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.907 2.405 . . . . 0.0 113.752 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -65.48 100.66 0.51 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.868 170.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.47 HD23 ' SG ' ' A' ' 442' ' ' CYS . 11.2 mp -67.66 129.41 39.83 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.2 19.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.649 -171.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -153.38 22.47 0.55 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.988 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 416' ' ' CYS . . . -132.55 174.94 20.19 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.436 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -82.46 -45.7 14.42 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 10.0 m-80 51.21 57.61 6.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.988 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 400' ' ' GLN . 16.5 mm-40 -67.3 -11.77 58.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.061 0.458 . . . . 0.0 110.466 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -110.49 8.35 23.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.445 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 60.7 t60 -73.16 154.82 40.15 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.509 174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 402' ' ' HIS . . . 89.41 -4.96 84.27 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.16 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -111.4 154.07 25.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 111.193 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -120.41 127.33 52.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.6 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -116.26 135.88 53.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.057 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 388' ' ' LYS . 9.8 p -75.81 159.91 5.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.334 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.734 ' OE1' ' HB2' ' A' ' 387' ' ' ARG . 1.2 mt-30 -51.9 127.14 20.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.09 -21.0 23.17 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.827 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -87.56 157.54 19.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.091 0.446 . . . . 0.0 111.665 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.497 ' CB ' ' HB ' ' A' ' 430' ' ' THR . 37.0 t -136.89 165.95 24.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.552 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.9 tp -173.52 140.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.8 p-10 -79.61 145.96 32.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.96 0.41 . . . . 0.0 110.263 175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.06 117.84 53.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.728 0.775 . . . . 0.0 110.804 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -83.63 111.42 19.11 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.678 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.48 ' HA ' ' HA2' ' A' ' 397' ' ' GLY . 60.9 m -106.91 165.07 11.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.454 177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -72.62 156.28 90.26 Favored Pre-proline 0 C--N 1.332 -0.191 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.124 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.89 111.14 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 123.367 2.712 . . . . 0.0 112.057 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 125.54 -23.51 6.0 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -106.37 134.32 49.68 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -153.62 159.49 42.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.362 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.844 ' HB2' ' O ' ' A' ' 426' ' ' GLN . 27.5 mt -75.26 143.0 75.97 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.906 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.888 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 73.6 Cg_exo -54.36 -119.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.475 0 C-N-CA 124.842 3.695 . . . . 0.0 111.479 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.687 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -89.45 11.63 18.76 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 158.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.888 ' HB3' ' HD2' ' A' ' 423' ' ' PRO . . . -67.68 -0.43 4.0 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.125 166.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.844 ' O ' ' HB2' ' A' ' 422' ' ' LEU . 23.2 mt-30 79.32 -148.33 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.266 159.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 8.4 p -123.1 -6.85 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.357 1.075 . . . . 0.0 108.104 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -129.54 143.98 51.07 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.313 -1.767 . . . . 0.0 110.11 -174.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.889 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.4 p -132.31 137.67 53.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.959 0.409 . . . . 0.0 109.969 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 0.2 OUTLIER -135.67 158.84 43.38 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -173.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 34.2 t -84.63 103.86 14.11 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.209 -1.359 . . . . 0.0 110.377 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.626 ' HB3' ' HB3' ' A' ' 437' ' ' SER . 13.4 ptm -96.61 -169.09 1.83 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 432' ' ' MET . 37.6 tt0 -46.08 -49.46 16.42 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.83 0.706 . . . . 0.0 112.02 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -118.03 51.06 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.708 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 101.63 -168.12 19.31 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.947 170.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.65 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 74.7 m95 -56.68 117.03 3.5 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.935 0.494 . . . . 0.0 110.253 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 432' ' ' MET . 1.9 p -76.22 -49.77 3.07 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -168.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.889 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 36.8 Cg_exo -62.98 -23.18 74.1 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.663 1.576 . . . . 0.0 111.381 172.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 438' ' ' PRO . 47.3 m 71.81 110.14 0.03 OUTLIER Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.846 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 58.2 Cg_endo -75.83 79.76 2.78 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.693 2.262 . . . . 0.0 112.149 -176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.419 ' HD2' HH11 ' A' ' 441' ' ' ARG . 11.8 ptm180 -139.44 101.3 4.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.219 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.47 ' SG ' HD23 ' A' ' 394' ' ' LEU . 17.2 p -92.5 125.49 37.17 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.527 0.68 . . . . 0.0 110.929 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.54 156.19 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.542 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -67.09 114.28 5.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.339 0.59 . . . . 0.0 109.976 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -93.08 -17.38 7.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.572 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.8 tttp . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.813 179.298 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 408' ' ' GLN . 6.4 mp . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 122.094 0.95 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' A' ' 387' ' ' ARG . 4.0 tpp180 -77.45 9.27 3.38 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.695 -1.593 . . . . 0.0 112.092 -174.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 58.32 162.22 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.628 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 1.7 m -137.18 100.26 4.21 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.9 -170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.651 ' CE1' ' HA2' ' A' ' 403' ' ' GLY . 50.5 t80 -71.48 131.35 43.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -87.79 113.95 56.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.12 174.22 11.03 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.203 2.602 . . . . 0.0 112.932 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -88.19 113.54 23.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.098 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 442' ' ' CYS . 7.0 mp -88.1 113.8 24.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.266 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -41.27 -59.81 1.43 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.977 0.798 . . . . 0.0 112.173 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.6 48.88 0.82 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.073 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -132.37 165.32 23.7 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -92.7 86.12 5.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.921 0.391 . . . . 0.0 110.272 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 402' ' ' HIS . 7.2 m-80 -89.16 70.92 8.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.119 -174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -70.6 -19.52 62.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.48 0.657 . . . . 0.0 109.39 173.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.531 ' CB ' ' HD2' ' A' ' 404' ' ' ARG . 8.2 p-10 -105.86 18.21 22.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.865 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 399' ' ' ASN . 22.0 t-80 -60.45 129.1 39.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 0.0 110.8 176.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . 0.651 ' HA2' ' CE1' ' A' ' 390' ' ' TYR . . . 97.29 -15.09 62.83 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.128 175.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.531 ' HD2' ' CB ' ' A' ' 401' ' ' ASN . 99.4 mtt180 -72.54 148.34 45.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.867 0.365 . . . . 0.0 110.226 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -121.72 112.0 17.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.739 -173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.38 -168.93 1.82 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.567 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 410' ' ' LYS . 10.0 p -134.83 157.24 40.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.67 ' HB3' ' HG ' ' A' ' 386' ' ' LEU . 8.8 tt0 -57.28 121.47 10.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 110.211 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 111.61 -17.88 25.31 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.968 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 407' ' ' VAL . 15.7 mmtp -86.99 149.65 24.62 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.133 0.492 . . . . 0.0 111.061 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.459 ' OG ' HG22 ' A' ' 430' ' ' THR . 40.4 t -126.13 165.91 17.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.844 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 6.0 tp -163.76 135.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 8.2 p-10 -83.29 145.93 28.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.835 ' HB ' HD21 ' A' ' 422' ' ' LEU . 40.0 t -111.56 132.84 59.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.872 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -100.22 89.99 4.19 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.51 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . . . . . . . . . 82.5 m -88.91 154.3 20.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 418' ' ' PRO . 17.4 m-70 -68.21 165.0 37.49 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.907 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 417' ' ' HIS . 44.3 Cg_exo -57.36 130.18 37.86 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 123.223 2.615 . . . . 0.0 112.343 -176.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 94.9 -11.23 69.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.207 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 52.0 m-85 -118.25 149.92 40.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.86 -0.2 . . . . 0.0 110.474 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -167.88 174.43 7.5 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.371 0.419 . . . . 0.0 109.896 176.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.835 HD21 ' HB ' ' A' ' 414' ' ' VAL . 1.5 mm? -66.49 169.6 7.23 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-O 121.227 0.536 . . . . 0.0 111.197 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.01 169.34 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.327 2.018 . . . . 0.0 110.491 167.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . 20.7 mtmt -77.86 58.71 1.95 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.252 1.025 . . . . 0.0 113.451 -161.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.68 40.76 0.84 Allowed 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 166.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.619 ' HB3' ' HB2' ' A' ' 422' ' ' LEU . 0.9 OUTLIER -96.74 108.99 21.73 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.533 -2.121 . . . . 0.0 115.601 -158.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 1.5 p -150.61 -4.47 0.33 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 112.565 -2.107 . . . . 0.0 106.787 153.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -166.13 176.57 7.56 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 111.073 -156.543 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.934 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -149.02 133.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.81 -1.087 . . . . 0.0 108.678 168.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 1.3 p -128.41 160.75 31.27 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.262 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 408' ' ' GLN . 5.2 t -94.91 110.32 22.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.148 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.58 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 25.9 ptm -88.27 -45.74 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.822 -173.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.473 ' N ' ' HG3' ' A' ' 432' ' ' MET . 38.7 tt0 -173.77 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -84.21 30.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.017 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . 103.4 -154.48 18.01 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.036 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.704 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -62.93 131.15 47.74 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.129 0.572 . . . . 0.0 111.134 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.676 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 40.5 t -81.45 -52.66 0.79 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.352 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.934 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 33.2 Cg_exo -62.81 -25.66 74.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.681 1.587 . . . . 0.0 110.901 174.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 441' ' ' ARG . 31.2 m 68.0 111.53 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.662 -176.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 20.4 Cg_exo -60.79 97.92 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.851 2.368 . . . . 0.0 111.929 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 439' ' ' THR . 6.3 ptm180 -156.83 113.81 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.591 177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 394' ' ' LEU . 71.5 m -79.0 74.93 5.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.614 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 4.8 pt -74.77 144.84 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.026 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -67.63 112.12 4.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.573 0.701 . . . . 0.0 110.368 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.418 HG21 HE22 ' A' ' 426' ' ' GLN . 9.8 p -96.24 -8.42 9.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.769 -174.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 21.2 tptm . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.03 -179.452 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 386' ' ' LEU . 9.0 mp . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 408' ' ' GLN . 0.0 OUTLIER 52.53 18.31 0.94 Allowed 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 121.958 0.885 . . . . 0.0 112.08 -174.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 407' ' ' VAL . 30.1 mmmt -153.14 149.95 28.58 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.392 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . 0.693 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 91.0 m -140.13 115.9 10.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 121.212 0.53 . . . . 0.0 112.091 -174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -83.9 136.85 33.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.662 170.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -86.05 116.01 64.11 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.94 169.93 13.91 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.081 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -94.4 122.7 37.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.597 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.621 ' HB3' ' HE1' ' A' ' 417' ' ' HIS . 7.3 mp -102.33 128.79 48.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -78.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.091 0.87 . . . . 0.0 112.267 -166.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -100.89 42.0 1.15 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.783 0.801 . . . . 0.0 109.74 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.99 30.11 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.97 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.708 ' HE2' ' CA ' ' A' ' 416' ' ' CYS . 2.1 p90 -71.59 53.47 0.22 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.527 1.131 . . . . 0.0 111.459 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 1.7 p30 -79.94 42.59 0.56 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -172.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.64 -17.0 60.14 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 165.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 404' ' ' ARG . 88.5 m-20 -90.71 -17.54 26.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 399' ' ' ASN . 16.9 t-80 -57.51 128.13 35.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.855 0.36 . . . . 0.0 110.223 174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 103.85 -10.19 52.1 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.78 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 401' ' ' ASN . 59.7 mtp180 -81.55 154.19 26.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.092 0.473 . . . . 0.0 110.551 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.17 124.34 44.48 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.031 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -117.28 164.36 14.94 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.121 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.472 ' HA ' ' HD2' ' A' ' 388' ' ' LYS . 11.7 p -115.4 156.18 16.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.734 ' NE2' ' HA ' ' A' ' 433' ' ' GLU . 31.6 tt0 -53.59 118.95 4.3 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.401 0.438 . . . . 0.0 110.098 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 113.51 -4.19 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.435 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -100.7 162.51 12.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.184 176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.482 ' OG ' HG22 ' A' ' 430' ' ' THR . 35.1 t -137.31 172.78 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.649 -174.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 7.8 tp -170.29 135.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.078 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 428' ' ' THR . 4.2 p-10 -81.76 136.57 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.666 0.746 . . . . 0.0 111.198 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.667 HG13 ' OH ' ' A' ' 398' ' ' TYR . 24.9 t -103.91 120.73 54.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.792 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -85.73 -27.8 25.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.05 0.929 . . . . 0.0 111.571 -174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.708 ' CA ' ' HE2' ' A' ' 398' ' ' TYR . 80.8 m 44.17 144.46 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.431 -163.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . 0.621 ' HE1' ' HB3' ' A' ' 394' ' ' LEU . 0.0 OUTLIER -62.04 138.93 95.9 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 113.256 -1.793 . . . . 0.0 109.119 176.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 417' ' ' HIS . 79.8 Cg_exo -45.55 111.83 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 123.96 3.107 . . . . 0.0 113.353 -175.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 115.52 -7.16 20.47 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.98 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . 0.754 ' HB3' ' HB3' ' A' ' 442' ' ' CYS . 91.2 m-85 -120.86 160.32 23.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.609 0.242 . . . . 0.0 110.544 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -157.24 156.31 32.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.018 176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 423' ' ' PRO . 16.2 mt -73.68 145.83 85.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.312 0.577 . . . . 0.0 110.96 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 422' ' ' LEU . 52.5 Cg_exo -56.56 144.42 85.02 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.889 3.059 . . . . 0.0 112.361 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 67.67 25.45 8.17 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.477 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 56.81 56.11 5.71 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.239 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -100.46 142.64 31.66 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.313 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 16.7 p -113.92 0.55 14.44 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.175 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 413' ' ' ASP . 0.2 OUTLIER -145.99 156.17 43.31 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.506 -173.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.865 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 2.5 p -139.45 134.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 436' ' ' TRP . 3.7 p -125.53 157.25 37.53 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.717 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . . . . . . . . . 17.8 t -87.03 99.39 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.786 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 435' ' ' GLY . 24.6 ptm -90.51 -157.32 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.734 ' HA ' ' NE2' ' A' ' 408' ' ' GLN . 43.5 tt0 -56.57 -55.8 29.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.658 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.63 51.8 0.93 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.693 ' HA2' ' SG ' ' A' ' 389' ' ' CYS . . . 80.1 -165.52 49.04 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.477 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.601 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 58.0 m95 -48.84 115.07 1.13 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.646 0.378 . . . . 0.0 110.041 178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.763 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.9 t -70.84 -55.53 6.75 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.446 -174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.865 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 37.9 Cg_exo -63.31 -28.33 72.15 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.037 1.825 . . . . 0.0 112.016 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 440' ' ' PRO . 62.3 m 69.61 113.4 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 O-C-N 123.731 0.644 . . . . 0.0 111.104 -176.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 436' ' ' TRP . 14.0 Cg_endo -79.11 80.75 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.81 2.34 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 441' ' ' ARG . 14.8 ptm180 -142.38 114.66 8.33 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 420' ' ' TYR . 63.7 m -81.98 118.02 22.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.322 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . . . . . . . . . 8.4 pt -86.64 144.01 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.673 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -69.65 120.27 15.16 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.374 0.606 . . . . 0.0 110.852 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.76 -31.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.266 -176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 446' ' ' LYS . 5.0 mmmp? . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.405 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.454 ' HG ' ' HG2' ' A' ' 387' ' ' ARG . 18.5 tp . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.133 0.492 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.454 ' HG2' ' HG ' ' A' ' 386' ' ' LEU . 2.3 mmp_? -101.46 79.62 1.98 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.11 175.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.758 ' HG2' HG23 ' A' ' 407' ' ' VAL . 34.6 mtmm -89.32 137.0 32.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 170.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' CYS . . . . . . . . . . . . . 19.7 m -109.24 136.39 48.78 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.557 -169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -100.3 126.96 46.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.567 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 402' ' ' HIS . 11.6 t80 -73.46 128.75 86.77 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.942 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -81.04 153.05 18.94 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.905 2.403 . . . . 0.0 113.218 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 402' ' ' HIS . 83.9 t80 -84.51 126.41 33.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.336 177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 397' ' ' GLY . 1.0 OUTLIER -93.49 144.42 25.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.312 0.577 . . . . 0.0 111.008 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -95.41 21.16 8.43 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -134.06 -31.81 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.93 -175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 394' ' ' LEU . . . 161.49 -153.32 24.06 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 119.983 -1.103 . . . . 0.0 114.128 176.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' TYR . . . . . 0.877 ' CD1' ' HA ' ' A' ' 416' ' ' CYS . 0.1 OUTLIER 39.73 26.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 165.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 402' ' ' HIS . 0.2 OUTLIER -102.77 43.6 1.06 Allowed 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.457 0.646 . . . . 0.0 110.559 171.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -67.55 -21.83 65.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.539 ' HA ' ' HD2' ' A' ' 404' ' ' ARG . 14.9 m-20 -103.9 -8.44 19.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.19 -174.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 391' ' ' PHE . 82.6 t60 -65.33 148.33 51.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.409 177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.73 -0.84 85.05 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.074 -173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.539 ' HD2' ' HA ' ' A' ' 401' ' ' ASN . 47.8 mtt180 -116.61 155.99 27.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -121.26 130.56 53.73 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.513 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 410' ' ' LYS . 72.8 m-85 -125.4 127.95 47.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.072 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.758 HG23 ' HG2' ' A' ' 388' ' ' LYS . 8.9 p -73.65 166.39 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.622 0.249 . . . . 0.0 110.731 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 407' ' ' VAL . 3.3 tp60 -45.31 127.94 7.43 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.324 0.65 . . . . 0.0 111.71 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 91.23 -8.32 79.51 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.847 -0.615 . . . . 0.0 113.472 177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 406' ' ' PHE . 33.2 mmtp -74.45 140.26 44.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.322 0.561 . . . . 0.0 110.958 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.457 ' CB ' HG22 ' A' ' 430' ' ' THR . 37.6 t -112.71 163.36 14.66 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.249 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.5 tp -170.31 146.46 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.098 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -80.03 151.78 29.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.64 0.734 . . . . 0.0 112.238 -177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 422' ' ' LEU . 22.0 t -114.08 132.76 62.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ALA . . . . . . . . . . . . . . . -114.07 86.62 2.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.253 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' CYS . . . . . 0.877 ' HA ' ' CD1' ' A' ' 398' ' ' TYR . 3.3 m -73.52 148.12 43.38 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.124 0.488 . . . . 0.0 111.547 -175.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.87 165.8 43.45 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.963 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.37 110.38 0.64 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.626 2.884 . . . . 0.0 111.93 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.451 ' HA2' ' HE2' ' A' ' 446' ' ' LYS . . . 112.55 -12.58 25.52 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.071 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -106.75 148.27 28.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.777 0.322 . . . . 0.0 110.811 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -156.43 145.64 20.51 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 414' ' ' VAL . 19.6 mt -62.75 141.75 97.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.925 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 443' ' ' ILE . 52.0 Cg_exo -55.85 -14.0 9.93 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 124.688 3.592 . . . . 0.0 114.799 -174.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.2 16.04 16.95 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.006 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 58.88 34.82 23.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.195 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -105.02 172.87 6.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.659 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.72 13.43 6.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.491 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.54 156.85 43.96 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.604 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 1.032 ' HA ' ' HG2' ' A' ' 438' ' ' PRO . 3.4 p -143.5 138.67 26.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.074 176.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' THR . . . . . 0.457 HG22 ' CB ' ' A' ' 411' ' ' SER . 1.4 p -131.42 154.12 49.0 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.13 178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 435' ' ' GLY . 0.9 OUTLIER -89.71 105.32 17.72 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.249 -0.581 . . . . 0.0 110.11 -177.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' MET . . . . . 0.588 ' HB3' ' HB2' ' A' ' 437' ' ' SER . 20.2 ptt? -81.11 -163.3 0.58 Allowed 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 432' ' ' MET . 4.3 tp10 -53.88 -54.91 32.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.298 0.571 . . . . 0.0 111.628 -175.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -97.76 28.32 3.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.488 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 431' ' ' CYS . . . 113.48 -175.1 16.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.162 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' TRP . . . . . 0.615 ' HB3' ' CG2' ' A' ' 429' ' ' VAL . 70.7 m95 -49.06 114.65 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.009 0.523 . . . . 0.0 110.073 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.728 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 42.5 t -73.42 -53.71 4.46 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.015 -171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 1.032 ' HG2' ' HA ' ' A' ' 429' ' ' VAL . 47.7 Cg_exo -59.88 -19.4 54.61 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.98 1.787 . . . . 0.0 111.654 174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' THR . . . . . 0.642 HG22 ' HG2' ' A' ' 441' ' ' ARG . 6.7 m 64.25 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.418 -176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 436' ' ' TRP . 58.7 Cg_endo -72.73 73.56 2.93 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.342 2.695 . . . . 0.0 112.5 -173.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . 0.642 ' HG2' HG22 ' A' ' 439' ' ' THR . 14.6 ptp180 -153.57 74.65 1.02 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.526 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 33.9 m -50.29 117.97 2.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 423' ' ' PRO . 11.3 pt -79.52 152.97 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.08 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -73.98 109.85 7.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.572 0.701 . . . . 0.0 110.648 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.64 -19.97 10.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.738 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.451 ' HE2' ' HA2' ' A' ' 419' ' ' GLY . 55.9 pttt . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.102 177.119 . . . . . . . . 1 1 . 1 stop_ save_